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ABSTRACT
Cell growth and development is regulated by the cell division cycle, which dictates 
how efficiently cells communicate with each other and is dependent on cellular morphology. 
Our lab focuses on a novel cell cycle regulator, Spy1A, which has been shown to enhance 
cellular proliferation and regulate mammary development. Elevated levels of Spy1A
significantly increased cell invasion, coincident with an increase -catenin transcriptional 
levels. We hypothesize that these characteristics may maintain cells in a more ‘stem-like’ 
state. Mammary stem cells are highly proliferative, they rely on adherence to surrounding 
cells for self renewal and invasion and migration into the mammary fat pad. We further 
demonstrate that Spy1A overexpression results in the formation of larger mammospheres, 
where mammosphere size has been correlative of stimulating stem cell self-renewal. Further 
resolving the roles of Spy1 in the developing mammary gland is essential to fully elucidate 
its roles in human disease. 
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1I. INTRODUCTION
Cancer is a relentless disease that claims the lives of millions of people of any 
race, ethnicity or gender. It is a disease that knows no limits with which it targets, leaving 
many of the glands and tissues in the human body susceptible to its strike. Of the many 
targets, breast cancer remains as one of the most prevalent cancers to affect women 
worldwide (Nudelman et al., 2009). In 2004, the World Health Organization determined 
that cancer caused 13% of all deaths worldwide, where breast cancer was ranked the fifth 
most leading cancer to affect overall cancer mortality (WHO Fact Sheet, 2009). This 
disease has become so frequent that its incidence rates have increased by 40% as the 
population ages (Nudelman et al., 2009). 
Breast cancer, like most cancers, is caused by a multitude of internal and/or 
external effects. It is through the interactions between genetic and environmental factors 
that cause a very complex, multi-stage process that encourages a normal mammary cell to 
become a tumorigenic. Abnormalities that occur within the tumorigenic cell can be 
attributed to carcinogens, which can damage the cell’s genome, and random mutagenic 
events that disrupt DNA replication by targeting well-orchestrated cellular events such as 
proliferation and apoptosis leading to the formation of tumors (Rudel et al., 2007). 
Although there are a multitude of factors that play a role in the cancer process, this thesis 
will focus on how a novel protein affects cellular and molecular mechanisms in 
mammary gland development and how Spy1 contributes to breast cancer.
Implications of Novel Cell Cycle Regulator, Spy1A in Breast Cancer
Mammary gland development is a tightly regulated process where misregulation 
of key events, such as proliferation or apoptosis, could lead to mammary tumorigenesis. 
2This delicate equilibrium is highly regulated by the cell cycle. The cell division cycle is a 
series of phases and checkpoints that ensure a cell is able to replicate and divide properly. 
The primary coordinated events can be organized into 4 phases: G1, S, G2 and M
(Schafer, 1998). During the cell cycle, there is a sequence of phosphorylation events that 
drives cells through the different phases and also includes various checkpoints that 
monitor the completion of critical events or delay cell cycle progression accordingly
(Schafer, 1998). The coordinated phosphorylation events are governed by a kinase family
called the cyclin dependent kinases (CDKs) (Malumbres, 2005). In order for CDKs to be 
activated they must be bound by a subunit, called cyclins that are transiently expressed. 
Together, CDKs and cyclins form an active complex that marks transitions in the cell 
cycle (Malumbres, 2005). A second type of cell cycle regulation is via checkpoint 
control, and this mechanism is especially important at times when problems are sensed 
during DNA replication and chromosome segregation (Vermeulen et al., 2003). These 
checkpoints are responsible for stopping the cell cycle, allowing DNA repair however if 
the damaged DNA is not reparable, then cellular apoptosis occurs and eliminates this 
damaged DNA (Vermeulen et al., 2003). Consequently, the association between cancer 
and the cell cycle is apparent, where the cell cycle program controls cellular proliferation 
and apoptosis and cancer is caused by disruption of these cellular events which leads to 
uncontrolled cell proliferation (Vermeulen et al., 2003). All types of cancers are 
characterized by uncontrolled cell numbers and these disproportionate cell numbers have 
been linked to a reduced sensitivity to signals that normally tell a cell to adhere,
proliferate, differentiate or undergo apoptosis accurately. 
3Although there are a multitude of genes that are involved in initiating and 
promoting cancer, this thesis will be focusing on a novel cell cycle regulator, named 
Speedy or Spy1, which belongs to a family of proteins called the Speedy/RINGO 
proteins. Xenopus Speedy (XSpy1) was first identified in a screen for genes that 
conferred resistance to UV radiation (LeNormand et al., 1999). Consequently, a screen to 
identify genes that are involved in G2/M transition in Xenopus oocytes demonstrated the 
existence of another family member, called Xenopus RINGO (Rapid Inducer of G2/M 
Oocytes). Together, Spy1 and RINGO formed a protein family of novel cell cycle 
regulators. During this screen, it was shown that expression of XRINGO in G2 arrested 
oocytes could increase meiotic maturation when compared to control oocytes that were 
induced with Mos expression or progesterone (LeNormand et al., 1999). Similarly, 
Spy1A2, another family member, could also increase meiotic maturation more efficiently 
than its control (LeNormand et al., 1999). However, our lab is interested in studying 
Spy1A1 (herein referred to as Spy1A), a family member that shares 40% sequence 
identity with its Xenopus counterpart (Porter et al., 2002). LeNormand and colleagues 
discovered that Spy1, a protein that has no known homology to cyclins, was capable of 
overcoming G2 arrest and could induce rapid oocyte maturation (LeNormand et al, 
1999). They also observed that in Spy1 injected oocytes that cdc2 kinase activity was 
stimulated, which lead to the discovery of Spy1 and its family members (LeNormand et 
al., 1999). This family of proteins contains a conserved region that is essential for binding 
to CDKs, called the Speedy/RINGO (S/R) box. It was later discovered that 
Speedy/RINGO protein could bind to and activate Cdk2, where certain family members 
could also bind and activate cdc2 (Porter et al., 2002) (LeNormand et al.,1999) It has also
4been demonstrated that Spy1 interacts with cyclin dependent kinase inhibitor, p27, where 
Spy1 can overcome p27 induced G1 arrest in vitro (Porter et al., 2003). It is known that 
numerous cyclin/CDK complexes are disrupted in different types of cancers, however of 
the Speedy/RINGO protein, one family member, Spy1A, stands out as showing great 
potential in understanding the process of mammary carcinogenesis. It was shown that 
Spy1A is ubitiquously expressed in most human tissues with high expression seen in 
thymus, liver, heart and testes. It was also observed through overexpression studies that 
Spy1 was capable of enhancing cellular proliferation through shortening the G1/S phase 
and that its abilities to enhance proliferation is dependent on Cdk2 activity (Porter et al., 
2002). Interestingly, overexpressed Spy1A has been correlated to breast cancer, where a 
serial analysis of gene expression (SAGE) on cells isolated from primary invasive ductal 
carcinoma showed that Spy1A was one of 50 upregulated genes expressed in this breast 
cancer subtype (Zucchi et al., 2004).
Evidence from our lab has demonstrated in more detail the role of Spy1A in 
breast cancer. Golipour et al determined that Spy1A levels, both RNA and protein, are 
elevated during puberty, early pregnancy and involution, which are highly proliferative 
events during mammary gland development in mice (Golipour et al., 2008). In addition, 
in vivo experiments demonstrated that Spy1A overexpression in Balb-c mouse mammary 
glands increased the rate of ductal morphogenesis, ductal side branching and also 
terminal end (TEB) bud elongation, where gland development was accelerated (Golipour 
et al., 2008). Additionally, in vitro studies done in our lab showed that Spy1A 
overexpression can disrupt acini development in HC11 differentation timecourse 
experiments (Golipour et al., 2008). Interestingly, a novel relationship between Spy1A 
5and c-Myc, a well known oncogene, was discovered. It was determined that Spy1A 
follows the same expression patterns as c-Myc during normal mammary gland 
development (Golipour et al., 2008). Though complete understanding of the role of Spy1 
in mammary gland tumorigenesis has yet to be achieved, this thesis will build upon 
previous work to further understand the contribution of Spy1 to many important aspects 
of mammary cell behavior which play a critical role in mammary tumorigenesis.
Structure of the Mammary Gland
The mammary gland is a dynamic organ that undergoes major changes in 
morphology during its development. The basic structure of the mammary gland consists 
of fatty tissue, called stroma, and a branching ductal system, which is referred to as the 
lobuloalveolar system (Richert et al., 2000). The lobuloalveolar system is composed of 
specialized structures, called the mammary acini (or also referred to as alveoli), that are 
vital for the functioning of the gland. Acini are pivotal in milk production, where their 
physical structure permits milk secretion (Richert et al., 2000). The mammary acini are 
spherical monolayers of epithelial cells that are composed of an inner lumen that is lined 
by a layer of milk producing cuboidal cells, which is surrounded by contractile, 
myoepithelial cells that are responsible for the expulsion of milk into the branching 
mammary ducts (Dontu et al., 2003). Moreover, the mammary acini unite together to 
form lobules wherein each lobule is connected to lactiferous ducts that empty into the 
nipple openings (VanHouten et al., 2003). Additionally, lobules join together to form 
lobes, where approximately 15-25 lobes are present within each breast (Watson et al., 
2008). The full development of the mammary gland involves the gland phasing through 
various development stages in order to become functional (Watson et al., 2008). 
6Mammary gland development is a complex, extensive and well orchestrated process that 
is not only essential for the correct patterning of the gland but it is also vital for its proper 
functioning. 
Mammary Gland Development
The mammary gland undergoes the majority of its development postnatally where 
a rudimentary epithelium is formed before birth. After birth, the rudimentary epithelium 
begins forming the branching network of ducts (Hennighausen et al., 2001). Throughout 
its development, the mammary gland goes through rounds of proliferation, apoptosis and 
differentiation which correspond to distinct developmental stages (Hennighausen et al., 
2001). Once the rudimentary epithelial tree is formed, the mammary gland undergoes a 
stagnant phase until the onset of puberty (Fata et al., 2003). In the first stage of mammary 
gland development, ductal branching is regulated through paracrine interactions between 
adjacent mesenchymal and epithelial cells (VanHouten et al., 2003). During these 
interactions, epithelial cells have the ability to proliferate, which allows them to invade 
the fat pad and establishes the beginning of ductal branching (Ball, 1998). As the 
maturing ductal tree contacts the boundaries of the mammary fat pad, the tips of the 
TEBs bifurcate and sprout to form the secondary branching structure (Chu et al., 2004). 
The secondary branching is stimulated by ovarian hormones, in which progesterone 
inhibits ductal branching differentiation and estrogen promotes ductal branching (Fata et 
al., 2003). Subsequently, mesenchymal cells, with the help of secreting factors, are able 
to alter mammary mesenchyme to form the lymph and blood vessels that encompass the 
mammary ductal tree which aids in the completion the ductal architecture (Robinson, 
2004). In the next mammary gland developmental stage, the period between puberty and 
7adulthood, the mammary gland forms to become fully functional but remains stagnant 
(Fata et al., 2003). 
At pregnancy, the mammary gland undergoes changes that allow the gland to 
perform its most vital task, milk production. For the gland to be capable of producing 
milk, the ductal branches experience a rapid period of proliferation which is stimulated 
by pregnancy related hormones such as estrogen, progesterone, and prolactin (Welsch et 
al., 1977) (Saji et al 2000). These hormones stimulate additional ductal branching, more 
affluent blood flow as well as cause an increase in adipose tissue (Saji et al., 2000). This 
rapid proliferation of the ductal branches leads to the formation of spherical epithelial 
structures, which will become the mammary acini (Fata et al., 2003). During mid to late 
pregnancy, the spherical epithelial structures begin to organize themselves where the 
innermost cells undergo apoptosis to aid in the creation of the acinar lumen (Debnath et 
al., 2008). This apoptotic event establishes the inner luminal epithelial layer where at the 
end of pregnancy, these luminal epithelial cells differentiate into alveolar cells, which are 
capable of synthesizing milk proteins (Bissell et al., 1989). After birth, the alveoli begin 
producing an abundance of milk due to the drop in progesterone levels and an increase in 
prolactin, a hormone that is responsible for regulating milk protein secretion and acini 
formation (Saji et al., 2000). The myoepithelial cells, that line that basal portion of the 
acini, play a vital role of directing milk secretion by providing the contractile force to 
expel milk out of the mammary acini. The contraction of the myoepithelial cells occurs 
through binding between prolactin receptor to essential extracellular matrix proteins, 
laminin and collagen (Bissell et al., 2005). With the coordination of systemic hormones 
8along with the differentiated mammary acini, the mammary gland serves its purpose for 
milk secretion during this crucial developmental stage (Stein et al., 2007). 
Once lactation is no longer desired, the mammary gland goes through its next 
developmental stage, the process of involution. There are a multitude of proteins that are 
involved in regulating involution however of these proteins; the one worth mentioning is 
Transforming Growth Factor Beta (TGF). TGFis responsible for regulating apoptosis, 
matrix remodeling and is also involved in regulating branching morphogenesis (Nguyen 
et al., 2000). Specifically, overexpression of TGF prevented lobuloalveolar 
morphogenesis which resulted in defects in lactation (Kordon et al., 1995). Involution 
allows the lactating mammary gland to be restored into its virgin form (Stein et al., 2007). 
This developmental stage is distinguished by massive tissue remodeling that involves: the 
collapse of the mammary acini, reorganization of mammary tissue and adipose tissue 
modifications. In general, involution is considered a two stage process, where the first 
phase focuses on breaking down the mammary acini, wherein mammary gland 
architecture is unaffected and the second phase focuses on reordering mammary gland 
structure (Debnath et al., 2008). In the first stage of involution, mammary tissue 
remodeling is restrained and apoptosis commences in the alveoli, an event that is 
triggered by the withdrawal of prolactin and oxytocin (Stein et al., 2007). In vivo studies 
have shown that when involution was forced upon in mice, the first step in involution, 
apoptosis of the mammary acini, lasted approximately 48 hours and this phase was 
reversible (Lund et al., 1996). It was shown that when mouse pups were returned to their 
mothers, undergoing involution, that apoptosis was stopped and that lactation resumed 
(Lund et al., 1996). The second stage in involution involves remodeling of the nearby fat 
9pad and reorganization of adipocytes (Watson et al., 2006). During this phase, the acini 
collapse and the stromal cells fill in the voids left behind by the destroyed acini (Debnath 
et al., 2008). There are a variety of proteases that are involved in the reorganization of the 
extracellular matrix such as the matrix metalloprotease (MMP) and serine proteases, 
which are secreted by stromal cells (Folguerras et al., 2004). It has been shown that the 
elimination of extracellular matrix promotes apoptosis of the alveolar cells and that the 
MMPs are responsible for activating this apoptotic event in addition to mediating 
remodeling of the mammary gland (Folguerras et al., 2004). Once the mammary gland 
has successfully completed involution, the resulting mammary gland is phenotypically 
identical to a virgin gland, where the gland is free to cycle through the previously 
mentioned developmental stages again (Motyl et al., 2007). 
Factors that Regulate Mammary Acini Development and Function
As previously mentioned, the mammary acini are the most vital structures within 
the mammary gland where emphasis relies on their bilayered structures. Experimentally, 
scientists have been able to culture analogous structures in vitro through the use of 
matrigel, which is a viscous protein concoction that is derived from Engelbreth-Holm-
Swarm mouse sarcoma cells (Debnath et al., 2003). Matrigel permits cells to grow in a 3-
dimensional (3D) environment that resembles in vivo conditions because of its diverse 
composition of laminin and collagen, important components of the extracellular matrix 
(ECM) (Gudjonsson et al. 2002). Specifically, the normal human mammary cell line, 
MCF10a, is an example of a cell line that is capable of forming acinar structures that are 
similar to those found in the mammary lobules (Debnath et al., 2005). In the recent years, 
a xenograft model for human breast cancer was derived from the MCF10a. Cell lines 
10
from this model encompass the entire range of human breast cancer from normal tissue 
(MCF10a) to malignant, metastatic tumors (MCF10CA1a) (Rhee et al., 2008). From the 
three dimensional experiments that have been performed to look more in depth into 
structure of the mammary acini, researchers have determined possible causes for breast 
cancer, including the deregulation of signaling pathways and abnormalities in cellular 
mechanisms that potentially lead to mammary tumorigenesis. It is through studying 
normal mammary acini development and functioning that scientists are beginning to 
understand the possible causes for tumorigenesis with the mammary gland. There are a 
multitude of factors that contribute to the mammary acini structure however the ECM and 
cell-cell contacts play a major role in regulating acini morphogenesis (Bilder et al., 2003).
Extracellular Matrix
The extracellular matrix (ECM) consists of specific components that are involved 
in permitting the epithelial cells to maintain their shape and structure. The ECM is 
composed of two parts: an interstitial matrix and a basement membrane. The interstitial 
matrix is filled with gels of fibrous proteins and polysaccharides that provide a rigid 
cellular support whereas the basement membrane (BM) is a sheet like structure made 
from components of the ECM where epithelial cells attach (Borg, 2004). Specifically, the 
mammary ducts consist of an epithelial layer that is associated with a single layer of 
myoepithelial cells. A sheath of BM surrounds the ducts and the ducts are surrounded by 
outer ring of interstitial matrix. It is the myoepithelial cells that are connected to the BM, 
which are composed of laminin 5, laminin 1, collagen IV, fibronectin and other ECM-
related proteins (Albrechtsen et al., 1981). In order for cells to survive, they must be 
anchored to the ECM. However, cancerous cells lose their ability to adhere to the ECM, 
11
which is a feature that has been extensively linked to metastasis in cancer (Fata et al., 
2003). It has been shown that if epithelial cells in the forming acini, are not attached to 
the BM, they will undergo apoptosis and not form acini (Debnath et al., 2008). The ECM 
is involved in relaying messages to the acini so that cellular events, like proliferation, 
apoptosis and cell polarization, function accurately to form the appropriate structures. 
Epithelial cells detect the ECM through basally located integrins and non-integrin ECM 
receptors (Bisanz et al., 2005). Specifically, integrins are receptors responsible for 
mediating attachment between cells or cells and the ECM. The 2 integrins have been 
identified as being important for ductal morphogenesis, where 2 integrin knockdown 
studies have shown to cause a decrease in ductal branching (Debnath et al., 2005). These 
receptors are also involved in regulating the cell cycle, migration and cellular shape. In 
addition, O’Brien et al discovered that by disrupting the expression of integrin receptor   
2-1, cultured mammary acini could not properly form and underwent apoptosis since 
epithelial cells within the acini could not detect the ECM (O’Brien et al., 2002). In 
essence, the ECM must function properly in order for normal mamamary gland 
development to occur. 
Cell-Cell Contacts 
The structure of the mammary acini is highly dependent on cell-cell contacts that 
are regulated by a family of adhesion proteins, called the cadherin family (Runswick et 
al., 2001). For instance, the outer myoepithelial cells of the acini are connected to each 
other by P-cadherin cell-cell contacts, whereas the inner luminal cells are adhered to one 
another by E-cadherin (Bilder et al., 2003). Additionally, the myoepithelial cells adhere 
to the luminal cells by desmosomal cadherins, and it has been determined that 
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desmosomes are vital for the formation of the acini through their roles in correcting 
abnormalities in epithelial polarity (Bilder et al., 2003). Since the cadherin family plays a 
major role in helping to establish and maintain acini structure, it is not surprising that 
misregulation of this protein family have been observed in literature. Studies have shown 
that either downregulation or upregulation of E-cadherin causes mammary cells to 
become cancerous (Cowin et al., 2005). It was observed that E-cadherin expression was 
lost in ~85% in certain breast cancer subtypes, like invasive lobular carcinomas (ILC) 
(Cowin et al., 2005). It was determined that ILC was caused by the epigenetic silencing 
of E-cadherin, whose absent expression has characterized these tumors as being non-
invasive and properly differentiated (Droufakou et al., 2001). However, a small 
percentage of ILC’s show increased expression of E-cadherin, causing an aberration in 
epithelial polarity thereby defining a less differentiated and more invasive tumor 
phenotype (Droufakou et al., 2001). Additionally, aberrant E-cadherin expression has 
been linked to higher staged tumors as well as tumor invasiveness and this misregulation 
of E-cadherin has been identified in not only breast cancer, but also lung cancer and 
colorectal cancer (Murtagh et al., 2004). 
Structure of the Mammary Acini
Mammary acini are composed of two types of epithelial cells, which are a cell 
type that undergo cellular polarization. Cell polarization is a process where cells organize 
their intracellular structures along apical, lateral and basal axes which transduce signals 
to help organize cells intercellularly (Debnath et al., 2008). In the literature, mammary 
acini, grown in 3D, deposit BM components such as collagen IV and laminin 5 on their 
basal surface whereby epithelial cells are connected to each other through their lateral 
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membranes (Debnath et al., 2008). Subsequently, the apical and basal domains of the 
epithelial cell contain a distinct protein constitution that provides the axes specific 
properties that permits them to transport necessary molecules across the epithelial sheet 
(BM) (Zhan et al., 2008). Interestingly, all epithelial cells express E-cadherin, which is 
localized at the junctions between the lateral and apical axes (Runswick et al., 2001). 
Epithelial cells bind to each other by their extracellular domains and their intracellular 
domains primarily bind to the actin cytoskeleton via adaptor proteins, specifically E-
cadherin’s interaction with  and catenin (Zhan et al., 2008). These adherens junctions 
are vital for reinforcing epithelial cell shape as well as changes during tissue and gland 
development (Cowin et al., 2005). With respect to the mammary acini, apical-basolateral 
polarization occurs through the attachment of 6-4 integrin to the basement membrane 
(BM) (Schreider et al., 2001). It has been observed that mammary acini, whether derived 
from primary cells or immortalized MCF10a’s, express high amounts of 6-4 integrins 
in dense structures, called hemidesmosomes (Underwood et al., 2006). Hemidesmosomes 
are responsible for allowing the myoepithelial layer of the mammary acini to connect 
with the ECM through utilizing integrin proteins to promote adherence. Consequently, 
cell-cell adhesion between luminal and myoepithelial cells is through desomosomes that 
are structures that utilize the cadherin family for promoting cell-cell adhesion in the 
formation of the acini (Underwood et al., 2006). 
Existence of Mammary Stem Cells in the Mammary Gland
Mammary gland development is reliant on a variety of cellular events and cellular 
factors, like the cell-ECM and cell-cell contacts, that govern its proper formation and 
functioning. Conversely, the mammary gland is under another plane of regulation, which 
14
is at the level of cell fate decisions. The mammary gland is a prime example of tissues 
that contain adult stem cells not unlike the bone marrow, salivary glands and pancreas 
(Lombaert et al., 2008). With respect to the mammary gland, it is during the 
developmental stage of involution that the mammary gland is very reliant on the stem cell 
pool (Filimore et al., 2008). Studies have proven the existence of these mammary stem 
cells (MSCs) through utilizing serial fat pad transplantation techniques. In these 
experiments, it has been demonstrated that samples taken from any part of the mammary 
gland can give rise to mammary epithelial outgrowths that have total development 
capabilities no matter the developmental stage or age (Smith et al., 1988). With the 
discovery of MSCs, studies have shown that these cells are able to accumulate mutations 
because of their prolonged and quiescent nature (Woodward et al., 2005). To be able to 
study MSC, putative markers were identified, using flow cytometry, to detect cell surface 
markers that could be used to identify a definitive stem cell population. Surface markers 
that were denoted MSC populations were CD24-/CD44+ (Bissell et al., 2008). Studies 
done by Al-Hajj et al demonstrated that CD24-/CD44+ tumor cells showed an increased 
ability to form tumors when injected into NOD/SCID mice fat pads (Al-Hajj et al., 2003). 
They observed that as few as 100 CD24-/CD44+ cells were capable of forming tumors, 
whereas 10,000 tumors cells from the same population with phenotype CD24+/CD44-
were not able to form tumors showing that this particular subpopulation of cells possess 
stem cell characteristics (Al-Hajj et al., 2003). Unfortunately, it remains relatively 
unclear what the relationship between CD24 or CD44 expression, as well as other MSC 
surface markers, and how this could relate to these markers being potential drug targets 
(Bissell et al., 2008). There is a great interest in these cell surface markers because of 
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their potential in understanding molecular mechanisms however there is still much debate 
into whether it is possible to isolate a pure population of stem cells from the normal 
mammary gland. 
Consequently, the most definitive evidence that MSCs exist is through culturing 
structures in vitro called mammospheres. Mammospheres (MS) are solid, spherical 
structures that are grown in anchorage independent and undifferentiated conditions 
(Grimshaw et al., 2008). Studies have shown that when MS are grown in adherent 
conditions, cells from these structures can differentiate into multiple lineages such as 
myoepithelial, luminal and alveolar. Additionally, when MS are grown in matrigel, cells 
from these structures can differentiate and form branching structure analogous to those 
seen in the mammary gland (Liao et al., 2007). In the literature, it has been shown that 
MS composition consists of small population of stem cells, progenitor cells, 
differentiated cells as well as senescing cells (Dey et al., 2009). It has been demonstrated 
that with subsequent MS passaging, it is possible to enrich the stem cell pool within the 
MS (Grimshaw et al., 2008). Dey et al demonstrated that CD24-/CD44+ cells were 
capable of forming MS as opposed to subpopulations of cells that exhibited alternative 
phenotypes (Dey et al., 2009). They also postulated that the composition of MS from 
passage to passage varied because of the way the stem cell niche was responding to the 
culturing environment (Dey et al, 2009). Several factors are involved in regulating the 
stem cell niche such as: cell-cell interactions between stem cells and interactions between 
stem cells and ECM; each are capable of directing self-renewing abilities (Dontu et al., 
2003). In another study, Iorns et al suggest that during MS passaging the stem cell niche 
may become undesirable for stem cells (Iorns et al., 2009). They hypothesize that the 
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undesirable environment promotes an increasing population of senescing cells which 
could be forcing stem cells to differentiate thereby shifting the balance between 
stem/progenitor and differentiated cells (Iorns et al., 2009). In summary, the culturing of 
MS provides a method to study properties of mammary stem cells and their niche as well 
as to determine how specific molecular mechanisms alter stem cell decisions in a manner 
that may contribute to mammary tumorigenesis.
Signaling Pathways Implicated in Mammary Development, Stemness and Breast 
Cancer
In order to understand how misregulation of stemness and cellular processes 
could contribute to tumorigenesis, it is imperative to study signaling pathways that are 
known to be involved in mammary tumorigenesis. There are a myriad of signaling 
pathways known to control self-renewal and preservation of stem cells but to also play a 
role in contributing to tumorigenesis. Some examples are TGF, Notch, Wnt and c-Myc 
(Dontu et al., 2003). One example of regulating stem cell self-renewal is through the Wnt 
pathway whose role is essential during development but also contributes to 
carcinogenesis (Neaves et al., 2006). The Wnt pathway participates in various 
developmental events including cellular polarization, proliferation, self-renewal and 
differentiation (Cadigan et al., 1997). In the canonical pathway the presence of Wnt 
activates the intracellular signaling protein Dishevelled (Dsh) which subsequently 
inactivates glycogen synthase kinase 3 (GSK3), a negative regulator of catenin.  
catenin is then able to accumulate in the cytoplasm and then translocate into the 
nucleus where it binds to transcription factor family, TCF/LEF which promotes the 
transcription of Wnt-responsive genes including, cyclin D1 and c-Myc (Polakis, 2000). In 
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the absence of Wnt, GSK3 and a group of other proteins [axin and adenotamous 
polyposis coli (APC)] form the “catenin degradation complex” where catenin gets 
phosphorylated by GSK3 and casein kinase 1 (CK1) and then is sent to the proteosome 
for degradation (Polakis, 2000). With respect to tumorigenesis, it has been observed that 
catenin overexpression contributes to over 90% of human breast cancers and has also 
been linked to poor prognosis in breast cancer (Michaelson et al., 2001). 
There has been mounting evidence of the Wnt signaling pathway being involved 
in regulating self-renewal (Nusse, 2008). Inhibition of catenin in mammary alveolar 
progenitors has been shown to inhibit pregnancy stimulated proliferation as well as 
mammary development, where catenin has been associated as a survival signal for 
stem cells in the mammary gland (Tepera et al., 2003). As well, Anton et al were able to 
show that murine embryonic stem cells are reliant on catenin expression because of 
catenin’s ability to promote stemness by turning on the expression of stem cell 
associated genes such as Oct4 and Nanog (Anton et al., 2007). Considering the crucial 
role that Wnt plays in regulating molecular mechanisms contributing to cancer, there is 
considerable crosstalk among pathways that makes elucidating specific molecular 
mechanisms in cancer extremely difficult. Of all the crosstalk that Wnt participates in, an 
interesting example is the crosstalk that occurs between the E-cadherin and Wnt 
pathways. At the center of these two well-established pathways is catenin, whose 
connections are very much present in both E-cadherin and Wnt pathways, where its role 
are in regulating adhesion and various developmental events respectively (Cowin et al., 
2005). Serine/threonine phosphorylation of catenin or E-cadherin stabilizes the 
cadherin/catenin complex, increase cell-cell adhesion and depletes cytoplasmic catenin 
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(Daugherty et al., 2007). It has been observed that overexpression of cadherins reduces 
available catenin by sequestering it at the plasma membrane to promote cell-cell 
adhesion and actin cytoskeleton reorganization (Daugherty et al., 2007). Conversely, both 
Wnt and E-cadherin mediated cell-cell adhesion are essential for the organization and 
maintenance of stem cells. For instance, mammalian hematopoietic stem cells (HSC) 
have demonstrated reliance on Wnt signaling and nuclear catenin for permitting 
cellular proliferation and limiting their differentiation potential (Nemeth et al., 2007). In 
addition, HSC niche in bone marrow are dependent on HSC attachment to osteoblast 
through cell-cell adhesion (Nelson et al., 2004).
In order to understand how Spy1 could be affecting self-renewal, it is important to 
mention c-Myc, an oncogene whose expression Spy1A mimics during mammary gland 
development (Golipour et al., 2008). Studies have shown that c-Myc participates in many 
cellular functions, such as replication, growth, metabolism, differentiation and apoptosis, 
and has been associated with poor prognosis in breast cancer (Liao et al., 2000). 
Interestingly, studies have shown that c-Myc is capable of reprogramming mouse 
fibroblasts into embryonic stem-like cells, which are called induced pluripotent stem cells 
(Wernig et al., 2008). In addition, c-Myc has also shown its abilities to maintain the stem 
cell differentiation and self-renewal through the regulation of the hematopoietic niche
(Wilson et al., 2004). Additionally, Cdk2, Spy1’s binding partner in the cell cycle, has 
also shown links to affecting stem cell self-renewal. For instance, Jablonska and 
colleagues demonstrated that cdk2 -/- mice showed significant decreases in self-renewal 
capacity and an increase in neural progenitor cells, suggesting that Cdk2 plays an 
important role in regulating proliferation and self-renewing abilities of neuronal stem 
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cells (Jablonska et al., 2007). Interestingly, studies have shown that Cdk2 regulates c-
Myc’s ability to promote senescence, which may have affects with how stem cell self-
renewal is regulated (Jablonska et al., 2007). As well, Spy1’s other known interaction, 
p27 has some links with affecting progenitor cells but not stem cells. It was discovered 
that p27 plays no role in affecting stem cell number or self-renewal, but it is involved in 
maintaining progenitor cell pool size and proliferation in primary mouse mammary cells 
(Cheng et al., 2000). It is understood that alterations in cell fate, adhesion and migration 
are characteristic of cancer and that abrogated expression of Wnt and cadherin contribute 
to mammary tumorigenesis.
Epithelial-Mesenchymal Transition 
Mammary tumorigenesis is a process that is defined by misregulated signaling 
pathways, cellular processes and changes in morphology. It is a process that can 
transform tumor cells so that they are able to metastasize into different parts of the body. 
If tumors become metastatic then this has been correlated in promoting more advanced 
stages in cancer. In metastasis, cancer cells can spread from the initial tumor site, invade 
into the surrounding tissue, enter the bloodstream, travel through the bloodstream and 
then colonize a new site where the cancer cells can begin forming secondary tumor mass 
(Zetter, 1998). The epithelial-mesenchymal transition (EMT) is an example of a process 
that has been correlated to cancer invasion and metastasis in breast, colon and lung (Mani 
et al., 2008). EMT is a process where cells undergo a developmental switch from a low 
motility epithelial phenotype to a highly mobile, mesenchymal phenotype (Perez-
Pomares et al., 2002). EMT has been proven to be essential for certain developmental 
events such as formation of tissues and organs, such as the heart and the peripheral 
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nervous system (Mani et al., 2008). Specifically, EMT has been able to promote 
metastasis through its abilities to disrupt the normal functioning of specific cellular 
events as well as downregulate important factors that prevent cancer cells from becoming 
metastatic (Perez-Pomares et al., 2002). Studies have characterized EMT as cells 
possessing a loss of E-cadherin expression, a gain of N-cadherin and increased cellular 
migration.
The induction of EMT has been under the control of the TGF pathway 
coordinating with the Ras pathway (Huber et al., 2005). Several additional pathways have 
been associated with EMT including Wnt, Notch and Hedgehog, and coincidentally these 
pathways have shown to be essential in stem cell function and early development as well 
as in cancer (Huber et al., 2005). However, for the scope of this thesis, only the Wnt 
signaling pathway will be highlighted with respect to its role in EMT. In the canonical 
Wnt pathway, catenin levels and stability to its TCF/LEF transcription partner are 
enhanced when E-cadherin is degraded or when GSK3 is inhibited by the PI3K pathway 
(Nelson et al., 2004). Researchers are becoming aware that misregulated E-cadherin is 
one of the key events in EMT (Huber et al., 2005). Numerous EMT inducing regulators 
repress E-cadherin transcription by means of interacting with specific E boxes in the E-
cadherin promoter. Some common examples of transcriptional regulators of E-cadherin 
are Snail and Slug, where Snail has been identified as the more common E-cadherin 
repressor in mammary tumorigenesis (Cowin et al., 2005). In vivo studies show that mice 
that lack Snail expression are embryonic lethal because of a defective EMT and constant 
expression of E-cadherin (Batlle et al., 2000). Another example of an E-cadherin 
repressor is Twist, a helix-loop-helix transcription factor that regulates cellular events 
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during gastrulation (Yang et al., 2004). With respect to EMT, studies by Yang and 
colleagues demonstrated that when Twist was knocked down in the 4T1 cell line, cells 
were able to metastasize into the lungs during fat pad transplant experiments. As well, 
Twist overexpression, in human epithelial cell lines, induced EMT and transcriptionally 
repressed E-cadherin (Yang et al., 2004). 
Although E-cadherin regulation represents only part of the understanding behind 
EMT, other candidate genes, such as c-Myc and N-cadherin, have been proving 
themselves as worthy targets for EMT. Studies have shown that c-Myc when ovexpressed 
has been shown to decrease cellular migration and invasion (Alfano et al., 2010). In 
addition, c-Myc has also been shown to cooperate with TGFto induce EMT through 
activation of Snail (Smith et al., 2008). Cowling and colleagues were able to show that c-
Myc overexpression lead to changes in mammary epithelial cell morphology from a 
cuboidal to a fibroblastic phenotype (Cowling et al, 2007). This research group also 
showed that overexpressing c-Myc mammary epithelial cells exhibited less contact 
inhibition than their controls, which suggests that c-Myc could be influencing EMT 
(Cowling et al., 2007). Alternatively, another study showed that c-Myc overexpression 
enhanced invasion in highly metastatic breast cancer cells (Coma et al., 2010). 
N-cadherin is a pro-migratory cell adhesion protein and has been directly linked 
to metastasis (Hazan et al., 2000). Early studies have found that increased N-cadherin 
expression disrupted migration, invasion and was later shown to promote metastasis in 
immortalized cancerous mammary cell lines (Niemana et al., 1999). Hazan et al 
demonstrated that N-cadherin overexpression lead to increased invasive and migratory 
abilites in weakly metastatic cells, MCF7 as well they were able to demonstrate N-
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cadherin’s abilities to promote metastasis in mice (Hazan et al., 2000). Derycke et al 
determined that N-cadherin’s ability to promote metastasis results from a synergistic 
interaction with fibroblast growth factor receptor (FGFR) via N-cadherin’s extracellular 
domain, which stabilizes FGFR and sustains matrix metalloproteinase-9 production 
(Derycke et al., 2004). While the relationship between E-cadherin and N-cadherin in 
EMT remains elusive, the fact that EMT plays a role in metastasis cannot be ignored for 
it adds yet another level of complexity in the pursuit of clarifying mammary 
carcinogenesis. 
EMT acts as an important mechanism for metastasis, where cellular events such 
as increases in migration, decreases in adhesion and increases in invasive abilities prompt 
tumor cells to metastasize to different parts in the body. Grzesiak and colleagues found 
that pancreatic cancer cells showed decreases in adhesive abilities as well as increases in 
migratory abilities through misregulation of E-cadherin and -catenin (Grzesiak et al., 
2005). In addition, Cheng and colleagues determined that Akt downregulation, a protein 
whose overexpression has been correlated to highly aggressive breast cancers, leads to a 
reduction in migration as well as invasion (Cheng et al., 2007). However metastatic 
cancers are not all created equal, and there are cases where typical characteristics were 
not observed in metastatic tumors. For instance, Sander and colleagues demonstrated that 
overexpression of T-lymphoma invasion and metastatic gene 1 (Tiam-1), which regulates 
cell invasiveness, could decrease migration and invasion but enhance cell proliferation 
(Uhlenbrock et al., 2004). Yakshibaeva and colleagues showed that metastatic lung 
carcinoma cells had lower migratory rates than their controls from transplantation 
experiments (Yaskshibaeva et al., 2002). Gilles and colleagues showed that cervical 
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carcinomas upregulate vimentin which caused lymph node metastasis, however when the 
metastases were collected, the tumors had lost vimentin expression (Gilles et al., 1996). It 
should be emphasized that primary tumors are heterogeneous, which makes it possible 
for tumors to exhibit classic signs of metastasis but not become metastatic (Fiddler et al., 
2003) (Thompson et al., 2005). With this being said, it is essential to maintain an 
unbiased perspective for understanding cancer progression, since this is a research field 
that does not follow the expression, “one size fits all”. 
Since the role of Spy1A in promoting mammary tumorigenesis is largely 
unknown, this thesis will explore the multifaceted role of Spy1A as a novel target for 
mammary tumorigenesis. Some questions that will be asked are: How does Spy1 
manipulation affect the development of the mammary acini? What role does Spy1 play in 
affecting stem cells within the mammary gland? How are cellular events like migration, 
adhesion and invasion affected by Spy1 manipulation? The following data to be 
presented in this thesis further builds upon previous work and continues to shed more 
light into the role of Spy1A in mammary tumorigenesis.
Hypothesis
Spy1 affects various cellular events in mammary gland development, and misregulation 
of Spy1 contributes to mammary tumorigenesis.
Objectives
1) To elucidate the role of Spy1 in cellular events regulated by the Wnt pathway.
2) To assess the role of Spy1 in stem cell self-renewal.
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II. DESIGN AND METHODOLOGY
Cell lines Utilized
Mammary cell lines: MCF10a, MCF7, MCF7 pLXSN, MCF7 pLXSN Spy1, MDA-MB 
231 pLKO, MDA-MB 231 pLKO Spy1, MCF7 pLKO, MCF7 pLKO Spy1, MDA-MB 
231 pEIZ, MDA-MB 231 pEIZ Spy1. Mouse Mammary cell lines: HCll, HCll pEIZ, 
HC11 pEIZ Flag Spy1 Other cell lines: Human Embryonic Kidney cells (HEK) 293.
Cell counts were performed utilizing Trypan blue exclusion.
HC11 wildtype and stable cell lines
HC11 wildtype and stable cell lines were grown in RPMI 1640 (Sigma#: R5886), 
10% newborn calf serum (Sigma#: N4637), 10 l/mL insulin, 5 mL Pen/Strep (per 500 
mL media), and 20 ng/mL human Epidermal growth factor (Gibco). 
MCF7 wildtype and stable cell lines
MCF7, MCF7 pLXSN, MCF7 pLXSN Spy1, MCF7 pLKO, and MCF7 pLKO 
Spy1 stable cell lines were grown in RPMI 1640 (Sigma), 10% Calf serum (Sigma#: 
C9676), and 5 mL Pen/Strep (per 500 mL media) (Gibco).
MDA-MB-231 Stable cell lines
MDA-MB-231 pEIZ, 231 pEIZ Spy1, 231 pLKO, and 231 pLKO Spy1 were 
grown in DMEM (Hyclone#: SH30022), 10% Fetal bovine serum (FBS) (Hyclone#: 
SH30070), and 5 ml Pen/Strep (per 500 mL media) (Gibco).
HEK 293 cell line
HEK 293 cell line was grown in DMEM (Hyclone#: SH30022), 10% fetal bovine 
serum (FBS) (Hyclone#: SH30070), and 5 ml Pen/Strep (per 500 mL media) (Gibco).
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Establishment of Stable Cell lines
Knockdown Spy1 stable cell lines (pLKO/pLKO Spy1) for MDA-MB-231 and 
MCF7 were established in the following manner. Eighty thousand cells were seeded onto 
a 24 well plate and grown overnight in 500 l of growth media that contained 10% serum 
and no penicillin/streptomycin. The next day and one hour before infection, media was 
changed to 500 l serum free and antibiotic free media. Multiplicity of infection (MOI) 
for these infections was 10 and the virus titer for both control and shSpy1 was 107 titer 
units (TU). To the serum and antibiotics free media, 10 g/ml polybrene was added then 
virus was added. Plates were rocked back and forth and side to side twice and left to 
incubate for 6 hours. After 6 hours, media was aspirated and fresh 500 ul of growth 
media containing 10% serum and no antibiotics was added. Since the control and 
knockdown vector had puromycin selection, 1g/ml puromycin was added to begin 
selection and media with puromycin was changed every 2 days. Control cells for both 
MCF7 and 231 pLKO died after 3 days while, 231 pLKO Spy1 control cells died after 5 
days. 
Overexpressing Spy1 stable cell lines (pEIZ and pEIZ Spy1) for MDA-MB-231 
was established in the following manner. The day before infection, 20,000 cells were 
seeded onto a 24 well plate with 500 ul of growth media that contain 10% serum and no 
antibiotics. The following day, growth media was changed to 500 ul serum and 
antibiotics free media containing 10 g/ml polybrene. MOI for this infection was also 10 
and the virus titer for both pEIZ and pEIZ Spy1 was 107. Virus was left on cells to 
incubate for 6 hours and after 6 hours, media was changed to 10% serum with no 
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antibiotics. Since pEIZ has no selectable marker but instead has fluorescence marker, it 
took approximately 7 days for pEIZ and 12 days for pEIZ Spy1 fluorescence to be robust.  
Plasmid Construction
Lentiviral vector pEIZ Spy1 was constructed by cutting Spy1, using restriction 
sites EcoRI and XbaI, from pJT013 Spy1+NdeI expression vector, and ligating it into the 
pEIZ backbone using the same restriction sites (gift from Dr. Bryan Welm).  
Transfection Method
HEK 293 were grown to 50-60% confluency using media that contained 10% 
FBS (Hyclone), 5 mL Pen/Strep antibiotic (Gibco) prior to transfection. On the day of 
transfection, growth media was changed four hours prior to transfection to complete 
growth media. Cells were transfected with 5 l PEI (10 mg/mL stock) and 50 l of 150 
mM NaCl. Cells were lysed 16 hours post transfection. Cells were lysed with 0.1% NP40 
Lysis buffer, 1l/mL Leupeptin (Sigma#:L2884), 0.5 l/mL Aprotinin (Sigma#: A6103) 
and 10 l/mL PMSF (Sigma#:P7626) and were lysed for 60 minutes on ice. Protein
concentrations were determined using Bradford assay where 2 uL of protein sample was 
diluted in 198 l of Bradford reagent and concentrations were calculated using Victor 
Plate Reader spectrophotometer. Western blot analysis was used to verify transfection 
efficiency. After transfer, PVDF membranes were blocked in 1% milk (1g skim milk 
powder, 100 mL TBST) and then probed with various primary antibodies (c-Myc: 
1:1000; -catenin: 1:1000; actin: 1:1000; flag mouse: 1:2000). E-cadherin, N-cadherin 
and Novus Spy1 primary antibodies were blotted at a ratio of 1:1000 in 1% Bovine 
Serum Albumin (BSA).  Corresponding horseradish peroxidase secondary antibody 
(1:10000) was utilized to detect protein expression. Exposure times for antibodies were 
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as followed: Actin (1 minute), -catenin (15 minutes), c-Myc (9 minutes), E-cadherin (6 
minutes), N-cadherin (6 minutes), Spy1 (8 minutes) and Flag mouse (11 minutes). For 
chemiluminescence, equal parts of luminol and 1% hydrogen peroxide were utilized to 
visualize protein expression.
Three Dimensional (3D) Culture
Three dimensional cultures were utilized to grow mammary acini using non-
tumorigenic MCF10a. To construct 3D cultures, Cultrex (Trevigen, catalog#: 3223-001-
01) basement membrane extract (BME) was used in an overlay format. In the overlay 
method of 3D culturing, 3 or 4 glass coverslips (Fisherbrand microscope cover glass 
circles, catalog#: 12-545-80) were placed in a 35 mm tissue culture plate. Coverslips 
were then coated with 30 l of undiluted Cultrex, and incubated for 15 minutes at 37oC to 
allow for solidification of Cultrex. After solidification, 1500 cells in 30 l complete 
media were seeded onto the coated coverslips. The complete media used for MCF10a 
was DMEM-F12 containing 2% heat inactivated horse serum (Sigma, catalog), 10 g/ml 
insulin (Sigma), 5 ng/mL human recombinant EGF (Gibco), and 0.5 g/ml 
hydrocortisone. 
Mammosphere Culture
MCF7 and 231 stable cell lines were utilized for mammosphere (MS) culture. 
Mammosphere (MS) culture for MCF7 and 231 stable cell line utilized MEGM Bullet kit 
(Clonetics, catalog #: CC-3150), 10 ng/mL human epidermal growth factor (Gibco), and 
20 ng/mL human basic fibroblast growth factor (Invitrogen, catalog#: 13256-029; stock 
25 g/mL; dissolved in 20 mM Tris, pH 7.5), and 4 g/mL heparin (Sigma#: H0777, 
stock: 140 units; dissolved in 50 mg/ml sterile distilled water).  For all stable cell lines, 
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mammospheres were seeded 50,000 cells/ per well using low attachment plates (Corning, 
catalog#: 3471) grown for 7 days and then passaged. Mammospheres were fed with 10 
ng/mL epidermal growth factor and 20 ng/mL fibroblast growth factor with 1 mL of fresh 
MEGM every 4 days. To dissociate mammospheres for passaging, 0.25% Trypsin 
(Hyclone) was added to MS culture and allowed to trypsinize for 8 minutes at 37oC. 
Dissociated mammosphere cultures were collected in 15 mL conical tubes and 1 mL of 
FBS was added and then cultures were spun down for 5 minutes at 800 rpm. Dissociated 
mammospheres was subjected to trypan blue exclusion assay to ensure equal numbers of 
cells were seeded in the low attachment plates.  
Clonal Assay
To assess sphering ability, MCF7 and 231 stable cell lines were seeded onto a 96 
well ultra low attachment plate (Corning, catalog#: 3474). Using serial dilution, 10 cells
were seeded per well in 100 l of MEGM (Clonetics) containing 10 ng/mL human 
epidermal growth factor (Gibco), and 20 ng/mL human basic fibroblast growth factor 
(Invitrogen) and were incubated at 37oC for 7 days. During this time, cells formed 
spheroids structures. To calculate the percentage sphering within a well, the following 
equation was used:
                                     % Sphering = # of spheres formed  X 100%
                                                           10 cells
Migration Assay
Migration assay used was adapted from Cell Biolabs protocol. Migration assays 
were was performed in 12 well plates using 8 m cell inserts (BD biosciences, catalog#: 
353093). Cells were treated with 20 mM NaCl (control) and 20 mM LiCl to see effects of 
the presence and absence of GSK3. Cells were seeded, transfected and the day after 
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transfection, cells were utilized in the migration assay. In a 12 well plate, 1 ml of 
complete growth media was placed into each well, then cell inserts were placed one hour 
prior to assay.  Cells were counted using trypan blue exclusion and making a cell 
suspension that contained 500,000 cells per mL of serum and antibiotic free media was 
prepared. 300 l of cell suspension was seeded into each insert and cells were allowed to 
migrate at 37oC for the various timepoints as indicated. Upon collection at each 
timepoint, cell inserts were removed and the interior of the insert was washed with a
distilled water dampened Q-tip, and then stained with 400 l of crystal violet stain (Cell 
Biolabs, catalog#: CBA-100) for 10 minutes at room temperature.  Cell inserts were 
gently washed with distilled water and allowed to dry for 10 minutes. Pictures of the 
stained cell inserts were taken at this point. Cell inserts were transferred to an empty well 
that contained 200 l of cell extraction solution (Cell Biolabs, catalog#: CBA-100) and 
was incubated for 10 minutes. 100 l of each sample was transferred to a 96 well plate 
and the optical density (OD) was read at 590 nm.
Adhesion Assay
The adhesion assay was designed by Dr. Lisa Porter. Collagen and fibronectin 
plates were coated prior to the assay. To prepare collagen solution, 500 l of collagen IV
derived from rat (Sigma, catalog#: C7661) was dissolved in 14.5 ml of sterile 2N acetic 
acid. To coat plates, 100 l was used to coat the well of a 24 well plate. Collagen was 
added to the well and then was swirled around to coat the entire surface area of well and 
the remainder was used to coat the next well. Plates were allowed to dry for 20 minutes at 
room temperature and subsequently were stored at 4oC. To prepare fibronectin solution 
(Disclaimer: do not agitate or vortex fibronectin), add 10 l of 1 mg/ml fibronectin 
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solution (Sigma, catalog#: F2006) in 9990 l of sterile 1X PBS. 100 l was used to coat 
wells and wells were allowed to dry for 20 minutes. Coated plates were stored at 4oC. 
Prior to adhesion assay, cells utilized in this assay were either transiently transfected or 
were stable cell lines. On the day of the assay, cells were counted using trypan blue 
exclusion and 20,000 cells were seeded per well for various timepoints as indicated in 
growth media containing 10% serum and antibiotics. Upon collection at each timepoint, 
the growth media was aspirated and wells were washed with 1 ml of 1x PBS and then 
aspirated again. Two drops of Coomassie blue stain (~2 l) were added to each well and 
pictures were taken immediately. Then, 200 l of lysis buffer (1% NP40) was added to 
each well and then 100 l of each sample was transferred to a 96 well plate, and optical 
density (OD) was read at 590 nm. 
Invasion Assay
Invasion assay was performed in 24 well plates using using 8 um cell inserts (BD 
Biosciences). Each insert was coated with 100 l of undiluted Cultrex (Trevigen) and 
allowed to solidify for 15 minutes at 37oC. Transiently transfected cells as well as stable
cell lines were utilized in this assay. Cells were counted using trypan blue exclusion and a 
cell suspension containing 500,000 cells per mL in serum free and antibiotic free media. 
In a 12 well plate, 1 ml of growth media was added to each well and the cell insert was 
placed ½ hour prior to assay. 300 l of cell suspension was added to each insert and 
allowed to invade for 24 hours at 37oC. The next day, cell inserts were cleaned with a 
distilled water dampened Q-Tip and stained with 400 ul of crystal violet stain (Cell 
biolabs) for 10 minutes at room temperature. Cell inserts were gently washed with 
distilled water, were allowed to dry for 10 minutes and pictures of stained cell inserts 
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were taken. Then, cell inserts were placed into a well that contained 200 l of cell 
extraction solution (Cell biolabs) and were incubated for 10 minutes. 100 l of cell 
lysates was transferred into a 96 well plate, where the optical density (OD) was read at 
590 nm. 
-catenin Reporter Assay
Plasmids utilized in this assay were: M50 Super 8X TCF/LEF TOPFLASH 
reporter plasmid (Addgene) and M51 Super 8X TCF/LEF FOPFLASH mutant reporter 
plasmid (gift from Dr. R.T. Moon, University of Washington). HEK 293 cells were 
transfected with various combinations of 10 g of pCS3, myc Spy1 pCS3, pLKO, pLKO 
with M51 and M50. 293 cells were transfected on 6 cm plates, containing 5 ml of growth 
media, and 5 l of 10 mg/mL PEI, with 50 l of 150 mM NaCl. Once PEI, NaCl and 
DNA were added together, the mixture was vortexed, incubated at room temperature for 
10 minutes and in a dropwise manner the DNA mixture was added to plates. HEK 293 
were transfected for 16 hours. After 16 hours, cells were collected without trypsin and 
were centrifuged for 3 minutes at 800 rpm and the growth media was aspirated off. Cells 
were re-centrifuged to remove any remaining growth media. 50 l of growth media was 
added to each pellet as well as 50 l of Bright GLO Luciferase reagent (Promega). Then, 
50l of the luciferase mixture were added to a 96 well plate where luminescence (counts 
per second, cps) was measured at 440 nm. 
QRT-PCR
Quantitative real time PCR was performed utilizing SYBR green master mix 
(Applied Biosystems) to determine the relative expression of Spy1, CK18, CD24 and 
CD44 across monolayer and mammosphere passages. QRT PCR primers were designed 
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along exon-exon junctions and detected all isoforms of the target genes studied. Prior to 
QRT PCR, QRT PCR primers were verified by absolute quantification in order to verify 
that the gene of interest was only being amplified as well as proper conditions for QRT 
primers. For normalization of data, ΔCT values were calculated by subtracting CT values 
from the endogenous control (GAPDH) and the target. pEIZ monolayer was considered 
the calibrator for all QRT PCR reactions and all ΔCT values were compared against its 
ΔCT values to give the ΔΔCT value. Then, the equation 2- ΔΔCT was utilized to calculate the 
relative quantification for each target gene studied, where log RQ represents the fold 
change between the samples and the calibrator. The average of log RQ, log min RQ and 
log max RQ were calculated for each sample and was subsequently graphed. Standard 
error was calculated from the log RQ, log min RQ and log max RQ. 
RNA was extracted from mammospheres and mammary acini utilizing RNeasy 
mini-prep kit (Qiagen). Following RNA extraction, cDNA synthesis was carried out in 
the following method: Amount of cDNA synthesize was dependent on RNA 
concentration. The range of cDNA synthesized was between 100 ng-3000 ng. For 
instance, 100 ng of total RNA and water were added to make final volume of 8 l. Then, 
1 l of 10 mM dNTP, 1 l random primers, and 1 l oligo(dT). Then the RNA mixture is 
incubated at 65°C for 5 minutes. After 5 minutes, RNA mixture is put directly on ice. 
Then, 4 l of 5X FS Buffer and 2l of DTT were added to the mixture and incubated at 
42°C for 1 minute. Then 0.5 l of SuperScript II Reverse transcriptase was added to each 
tube and incubate at 42°C for 60 minutes. To inactive SuperScript II reverse 
transcriptase, tubes were incubated at 70°C for 15 minutes. Since mammosphere and 
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acini yield such little RNA and cDNA, the number of cycles utilized in every Q-PCR run 
was always 65 cycles.
Statistics
Statistics were performed using non-paired two sample t-test. Standard error was 
calculated as standard deviation (SD)/number of replicates (n).
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III. RESULTS
To further understand the role of Spy1 in mammary development, it is imperative 
to study how Spy1 affects various cellular events that are known to be targeted during 
tumorigenesis. Cellular events such as cellular migration, adhesion, invasion and 
stemness are processes that are essential for a cell to behave properly during normal 
development. However, misregulation of such processes has been linked to mammary 
tumorigenesis and can promote metastasis (Mahoney et al., 2002). These sets of 
experiments will involve documenting the role of Spy1 in migration, adhesion and 
invasion, and stemness. This work will further clarify the role of Spy1 in mammary 
tumorigenesis.
Cell line Rationale
Throughout these studies, four different cell lines were utilized: MCF7, MDA-
MB-231, HC11 and HEK 293. MCF7 & 231: The MCF7 cell line represent a cancerous 
breast cell line that are estrogen receptor (ER) positive as well as E-cadherin positive, and 
are representative of a luminal breast cancer subtype. The 231 cell line represent a basal 
breast cancer cell line that is ER and E-cadherin negative. Since 231 and MCF7 cell lines 
contain high levels of Spy1, it was essential to knockdown Spy1 expression to assess how 
various cellular processes would be affected. HC11 & 293: HC11 cells are normal mouse 
mammary cells derived from a mid-pregnant Balb/c mouse that have mutant p53 alleles. 
HEK 293 cells are human embryonic kidney cells that express vitronectin. For Spy1 
overexpression, it was important to use cell lines that did not express high levels of Spy1. 
Using these cell lines allow us to adequately investigate the effects of elevated levels of 
Spy1 on specific aspects of cellular function. In addition, while breast cell types are of 
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the primary importance to our work, these cell lines are notoriously difficult to 
manipulate gene expression. Hence, determining whether 293 cell lines follow the same 
physiological response in response to altered Spy1 levels is essential to facilitate the use 
of these cells for future pathway/molecular studies. 
Spy1 Knockdown Increases Cellular Migration
To assess the role of Spy1 in cell migration, stable knockdown of Spy1 was 
introduced into MDA-MB-231 (231) and MCF7 cell lines utilizing infection techniques 
with lentivirus. Stable Spy1 knockdown (pLKO-Spy1) and stable control (pLKO) cell 
lines were treated with 20 mM lithium chloride (LiCl) and 20 mM sodium chloride 
(NaCl), which served as a control.  20 mM Lithium chloride is utilized to mimic the Wnt
in that Li+ ions have been shown to inhibit GSK3 activity (Csenlenyi et al., 2008). It was 
important to study Spy1 expression in the presence and absence of LiCl to see if Spy1 
overexpression and knockdown was affected by GSK3 in order to further understand 
Spy1’s role in the Wnt pathway. Cells were subjected to a trypan blue exclusion assay to 
assess proliferation rates (Figures 1A 231; 2A, MCF7). MCF7 and 231 knockdown 
pLKO-Spy1 cells have lower cell numbers in comparison to the pLKO –control cells. 
Spy1 knockdown has been shown in literature to cause a decrease in cell number, so it 
was to be expected that Spy1 knockdown in both 231 and MCF7 would elicit lower cell 
numbers (McAndrew et al., 2009).Upon observing differences between 231 knockdown 
Spy1 cells treated with NaCl and LiCl, it appeared that NaCl treated Spy1 cells had 
higher cell numbers in comparison to the LiCl treated Spy1 cells. However in MCF7, 
Spy1 knockdown NaCl cells had lower cells numbers in comparison to LiCl treated cells 
(Figure 2A). Once cell numbers were obtained, 231 and MCF7 stable cells, with and 
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without LiCl, were seeded into a migration chambers where 3, 4, 5 and 18 hour 
timepoints were collected (Figure 1B; 231 & 2B; MCF7). For both 231 and MCF7 stable 
cell lines knock down of Spy1 expression increased the number of cells migrating 
through the polycarbonate chambers (Figure 1B; 231 & 2B; MCF7). These data were 
confirmed by collecting cells from the polycarbonate chambers, staining with crystal 
violet and measuring optical density at 590 nm (Figure 1C; 231 & 2C; MCF7). For both 
231 and MCF7, pLKO-Spy1 cells had higher optical densities than the pLKO control 
(Figure 1C; 231 & 2C; MCF7). However, an interesting relationship was observed in 
western blot analysis (Figure 1D). In the knockdown 231 experiments, -catenin levels 
appeared to be decreased in the presence of Spy1 knockdown. This may mean that in 
presence of active GSK3, Spy1 may be affecting -catenin levels. However in the 
presence of LiCl., there appeared to be an increase in -catenin levels, which may show 
that Spy1 does not affect -catenin levels in the absence of GSK3 (Figure 1D 231; 2D 
MCF7). In sum, reduced Spy1 expression results in an increase in cell migration in a 
manner which may not be dependent on GSK3, meaning that Spy1 may be affecting -
catenin levels in a way that does not fit with the known canonical Wnt pathway. 
Spy1 Overexpression Decreases Cellular Migration
To delve deeper into the role of Spy1 in cell migration, overexpression 
experiments were performed utilizing stable cell lines that were created through infection 
with lentiviral expression constructs.  Empty vector was used as a control (pEIZ) along 
with pEIZ-Flag Spy1 in non-tumorigenic immortalized mouse mammary cells (HC11). In 
addition, transient transfection methods were utilized on HEK 293 (293) cells to 
introduce Spy1 overexpression (myc-Spy1-pCS3) prior to the migration assay. LiCl or 
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NaCl control treated overexpressing Spy1 cells were subjected to trypan blue exclusion 
assay to assess proliferation rates. In both cell types, Spy1 overexpression results in 
significantly higher cell numbers in comparison to pEIZ and pCS3 (Figure 3A; HC11 & 
4A; 293). Spy1 overexpressing or control cell lines treated with LiCl or NaCl were then 
seeded into migration chambers where 3, 4, 5 and 18 hour timepoints were collected. In 
both cell systems Spy1 overexpressing cells had lower cell numbers migrate through the 
polycarbonate chamber in comparison to their pEIZ and pCS3 controls (Figures 3B; 
HC11 & 4B; 293). Then, cells were collected from their chambers, stained with crystal 
violet and their optical density (OD) was measured at 590 nm (Figure 3C & 4C). For the 
HC11 cells, there were statistically significant differences between pEIZ-Flag-Spy1 and 
pEIZ control cells during timepoints 3, 4 and 5 hours at the p<0.05 and p<0.001 levels 
(Figure 3C). For 293 pCS3-Myc-Spy1 cells, there was a statistically significant 
relationship between Spy1 overexpressing cells and their pCS3-control during all 
timepoints at the p<0.05 and p<0.001 levels (Figure 4C). Overexpression of Spy1 
increased -catenin levels in both NaCl and LiCl treated cells in the HC11 cells (Figure 
3D). However, 293 overexpressing Spy1 cells only showed higher -catenin levels when 
treated with LiCl (Figure 4D). E-cadherin levels appeared to be elevated in LiCl-treated 
cells in comparison to the NaCl-treated cells (Figure 4E). However, both control and 
treatment cells elicited constant E-cadherin levels (Figure 4E). To summarize Spy1 
overexpression effects on cellular migration, Spy1 caused fewer cells to migrate.
The results of Spy1 on cellular migration were not results that were expected. The 
original postulate for these experiments was that Spy1 overexpression would increase 
migration and its knockdown would cause a decrease in migration. The rationale behind 
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this postulate was that Spy1 has been shown to be upregulated in invasive breast cancers 
(Zucchi et al., 2004), and so it was thought that if Spy1 promote metastasis; a scenario 
where cells have acquired the ability to be more motile (Huber et al., 2005). It is possible 
that that Spy1’s potential interactions with Axin and LRP6 could be involved with 
stabilizing -catenin levels in metastasis, where -catenin levels have been shown to be 
stabilized in EMT (Huber et al., 2005).
Spy1 Knockdown Decreases Adhesion
Cell adhesion is a very important event involved in cell-cell and cell-ECM 
contact. Adhesion also plays a role in migration, where cell-substrate interactions are 
vital for permitting a cell to be mobile. It was with great interest to study the role of Spy1 
in cell-substrate adhesion after revealing significant effects of Spy1 on cell migration. 
Stable MCF7 and 231 knockdown Spy1 cell lines, infected with pLKO-control and 
pLKO-Spy1 lentivirus were subjected to a trypan blue exclusion assay to assess 
proliferation rates. Both MCF7 and 231 cells expressing pLKO-Spy1 expression 
demonstrated lower cell numbers than their controls (Figure 5A; 231, 6A; MCF7). 20,000 
stable cells were then seeded onto various substrates; plastic, collagen and fibronectin 
and cells were allowed to attach over 0, 4 and 24 hours. At each particular timepoint 
media was removed, cells were washed with 1X PBS and then stained with coomassie 
blue and pictures were taken. In both cell systems pLKO-Spy1 had fewer cells that 
attached on the collagen, fibronectin and plastic substrates (Figures 5B; 231 & and 6B; 
MCF7). Once photographs were taken, stained cells were put into lysis buffer and their 
OD was measured at 590 nm. Optical density of MCF7 and 231 pLKO-Spy1 cells were 
lower than their pLKO-control (Figures 5C; 231 & 6C; MCF7). The relationship between 
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Spy1 and -catenin was again observed in the 231 knockdown Spy1 cells in the presence 
of LiCl or NaCl control. In 231 cells, lower overall levels of -catenin were observed in 
the presence of Spy1 knockdown. (Figure 5D). However for MCF7 cells, -catenin levels 
could not be probed and only E-cadherin levels were observed. It appeared that Spy1 
caused an increase in E-cadherin levels (Figure 6D), which may mean that the absence of 
Spy1 could be allowing E-cadherin to recruit -catenin up to the plasma membrane to 
promote cell-cell adhesion and disrupt cell-substrate adhesion. To summarize the 
relationship between Spy1 and adhesion, it was determined that Spy1 knockdown reduces 
the number of cells that are able to adhere to plastic, collagen and fibronectin substrates 
in both MCF7 and 231 cells. 
Spy1 Overexpression Increases Adhesion
Since the knock down expression of Spy1 causes a decrease in cell adhesion, it 
was of great interest to see how Spy1 overexpression could affect the ability of cells to 
adhere to select substrates (plastic, collagen and fibronectin). 293 cells were transiently 
transfected with Spy1 overexpression vector (pCS3-Myc-Spy1)_ or the empty vector 
control (pCS3), and HC11 stable pEIZ-control and pEIZ-Flag-Spy1 were utilized in these 
assays. Proliferative abilities of 293 and HC11 cells overexpressing Spy1 were assessed 
using trypan blue exclusion assay. 293 pCS3-Myc-Spy1 and HC11 pEIZ-Flag-Spy1 had 
higher cell numbers than their pCS3 and pEIZ controls respectively (Figures 7A HC11; 
and 8A 293). 20,000 cells were then seeded onto the different substrates and were 
permitted to adhere for 0, 4, and 24 hours. At each timepoint, cells were washed with 1X 
PBS, stained with coomassie blue and photographs were taken. The results from these 
studies in 293 cells show that Spy1 significantly increases adhesion to the various 
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substrates over control (Figure 8B). These results were confirmed by measuring 
absorbance of 293 overexpressing cells over control (Figure 8C). The relationship 
between 293 overexpressing Spy1 and substrate adhesion yielded statistically significant 
results at the p<0.05 and p<0.001 for 293 Spy1 overexpressing cells adhering to collagen 
and plastic substrates (Figure 8C). 
In the HC11 cell line, cells overexpressing Spy1 (pEIZ-Flag-Spy1) had more cells 
adhere to the plastic and collagen substrates than the HC11-pEIZ controls (Figure 7B). 
This same trend was seen when optical densities were measured and was highly 
statistically significant (p<0.001) for early timepoints (0 and 4 h plastic and fibronectin) 
and statistically significant (p<0.05) during the last timepoint (24 h plastic, collagen and 
fibronectin) (Figure 7C). Subsequently, HC11 pEIZ-Flag-Spy1 cells appeared to have 
adhered less to the fibronectin substrate (Figure 8B), a trend confirmed by absorbance 
measurement (Figure 7C). In sum, Spy1 overexpression increases adhesion of 293 cells 
to all substrates tested and HC11 cells for both collagen and plastic matrices. However 
for the HC11 cells Spy1 overexpression inhibited adhesion to a fibronectin substrate. 
Spy1 Effects on Invasion
In cancer, literature has shown that changes in cellular migration, adhesion and 
ability to invade are hallmarks for metastatic tumors. Given the role of Spy1 on adhesion 
and migration, it was important to determine whether Spy1 could affect invasion. For 
these experiments, MCF7 stable Spy1 knockdown or control cells (pLKO-Spy1 or pLKO 
respectively) were used along with transiently transfected 293 cells to overexpress Spy1 
(pCS3-Myc-Spy1) or control (pCS3). Serum-starved cell suspension consisting of 
500,000 cells were seeded into cultrex-coated chambers and permitted to invade through 
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for 24 hours. The results from the study showed that MCF7 Spy1 knockdown cells 
caused reductions in the ability of cells to invade through the coated membrane (Figure 
9A). Along this same trend, 293 cells with elevated levels of Spy1 were able to invade 
through coated chambers more efficiently than their controls (Figure 9A). This same 
trend was seen when optical densities were measured (at 590 nm) after the assay. Results 
showed that MCF7 pLKO-Spy1 cells had statistically significant lower optical densities 
than the pLKO-control (p<0.001) and 293 pCS3-Myc-Spy1 cells had higher optical 
densities than relevant controls (p<0.01) (Figure 9B). In summary, Spy1 knockdown 
reduced cell invasiveness whereas Spy1 overexpression promotes cell invasiveness.  
Spy1 Effects on -catenin Transcriptional Activity
To gain more insight into the potential role of Spy1 in the canonical Wnt 
signaling pathway, it was important to study how Spy1 could affect -catenin signaling. 
To assess -catenin signaling in the presence of Spy1 overexpression in 293 cells, a 
luciferase reporter assay was performed to determine -catenin’s transcriptional activity 
using a -catenin reporter plasmid (TOPFLASH) and a mutant -catenin reporter plasmid 
(FOPFLASH). -catenin transcriptional activity was higher in 293 cells overexpressing 
Spy1 (pCS3-Myc-Spy1) in comparison to the FOPFLASH controls (Figure 10A). To 
summarize these findings, Spy1 overexpression increases -catenin transcriptional 
activity in the presence of activated GSK3, where LiCl treatments prevented Spy1 from 
affecting -catenin transcriptional activity (Figure 10A)
Spy1 Effects on Stemness
Previous research has shown that Spy1 is highly expressed during specific times 
in mammary gland development including puberty, early pregnancy and involution 
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(Golipour et al., 2008). As previously mentioned, the mammary gland undergoes major 
changes in structure and function during pregnancy and lactation, where expression of 
Spy1 has been shown to be elevated during this period of development (Golipour et al., 
2008). Specifically, involution is a stage where lactation is no longer needed and the 
gland undergoes massive restructuring to return back to its virginal state. During 
involution, signals are being sent to the mammary acini to undergo apoptosis, among 
other reconstruction events. At the same time, mammary stem cells present within gland 
are now being recruited to help in the restructuring and reorganization of the mammary 
gland. Stem cells are highly reliant on their niche, a microenvironment that promotes 
stem cell self-renewal through controlling events such as proliferation and adhesion 
(Brisken et al., 2007).  The cancer stem cell hypothesis has come to the forefront to begin 
to explain how tumorigenesis could arise. The hypothesis states that tumors arise from 
tumor cells that have acquired self-renewal abilities (Tan et al., 2006). Given that Spy1 is 
involved with causing mammary tumorigenesis, is highly expressed during involution, as 
well can affect cellular processes like adhesion, migration and proliferation, a few 
interesting questions stood out: Does Spy1 have any effects on mammary stem cells? 
What role could Spy1 have in affecting stemness? Or could Spy1 promote the expression 
“cancer stem cell”? These were a few questions that prompted studying Spy1’s role in 
affecting stem cell self-renewal.
To begin to answer these questions, a novel cell culture technique was utilized 
where it would be possible to work with stem/progenitor cells through promoting their 
growth in specialized culturing conditions. This new technique involves the culturing of 
structures called mammospheres (MS), where cells are seeded in non-differentiating and 
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anchorage independent conditions which promote the stem cells present in the population 
to form mammospheres. MCF7 and 231 cell lines were utilized in these experiments 
because both cell lines contain a small pool of stem cells. The ability for a stem cell to 
undergo self-renewal has been demonstrated through enriching the stem cell pool by the 
formation of mammospheres and then passaging these spheres, thereby releasing stem 
cells to begin to form more spheres with further passaging (Dey et al., 2009). It was of 
great interest to determine whether Spy1 could affect mammosphere size, numbers, 
passaging and sphering abilities. Overexpressing stable cell lines were generated using 
lentiviral pEIZ-control and pEIZ-Flag-Spy1 for the 231 cell system.  In addition, MCF7 
cells were previously created through retroviral infection using pLXSN-control and 
pLXSN-Flag-Spy1 (Golipour et al., 2008). Knockdown stable cell lines were created 
using lentiviral pLKO-control and pLKO- Spy1 for both MCF7 and 231. Stable cells, 
both overexpression and knocking down Spy1 expression, were seeded into ultra low 
adhesion plates and grown in serum free media, supplemented with epidermal growth 
factor (EGF) and fibroblastic growth factor (FGF), for 7 days and then passaged four 
times.
For the overexpression study, the results show that for both 231 and MCF7 
overexpressing Spy1 cells had statistically larger diameters than their controls (Figure 
11A I-II; overexpression Spy1 MS & 11A III-IV; Knockdown Spy1 MS). For the MCF7 
MS, there was a statistical difference between pLXSN and pLXSN Spy1 in passages 1, 2, 
and 4 at the p<0.05 and p<0.001 levels (Figure 11B). Whereas, the 231 pEIZ-Flag-Spy1 
stables showed statistical differences between pEIZ-control and pEIZ-Flag-Spy1 in all 
four passages at the p<0.001 level (Figure 11B). Next, the numbers of MSs were counted 
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between passages comparing numbers between the overexpressing Spy1 cells and their 
controls. MCF7 pLXSN-Flag-Spy1 generated higher numbers of MSs in the first two 
passages when compared to the pLXSN control MS’s (Figure 11B). High statistical 
significance was only observed during passage 3 between MCF7 pLXSN-Flag-Spy1 MSs 
and pLXSN-control MSs (Figure 11B). Conversely, 231 pEIZ-Flag-Spy1 MSs generally 
had lower numbers of spheres formed than the pEIZ-control (Figure 11B). 
For the knockdown studies, the 231 pLKO-Spy1 cells showed a cyclical trend 
where diameter varied across passages (Figure 11B). For instance, 231 pLKO passage 1, 
3 and 4 MSs were larger than 231 pLKO-Spy1 counterparts (Figure 11A IV. and B). 
However, 231 pLKO-Spy1 passages 2 MSs had larger diameters than pLKO-control 
(Figure 11A and B). There were differences between 231 pLKO-Spy1 and pLKO-control 
MSs in every passage (Figure 11B). With respect to number of spheres, there were 
variations with respect to passage number in number of spheres formed between the 
control and knockdown Spy1 MSs (Figure 11A).  In passages 1 and 4, more spheres 
formed in the controls than the 231 pLKO-Spy1 spheres. However in passages 2 and 3, 
more spheres had formed in the 231 pLKO-Spy1 than in the control (Figure 11B). 
For the MCF7 knockdown study, it appeared that the MCF7 pLKO-control were 
forming MSs that were larger than the MCF7 pLKO-Spy1 in passage 1 (Figure 11A III). 
However in passage 2, no spheres formed in the MCF7 pLKO Spy1 cells (Figure 11A 
III). There were statistical differences between the MCF7 pLKO control and MCF7 
pLKO-Spy1 mammospheres (Figure 11B). Subsequently, the number of MSs was 
counted and numbers were compared between MCF7 pLKO control and MCF7 pLKO-
Spy1 MSs across passages (Figure 11B). For the MCF7’s, the pLKO-Spy1 MSs yielded 
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lower numbers of spheres formed than the pLKO-control and this relationship was shown 
to be statistical significant in both passages, at the p<0.05 and p<0.001 levels respectively 
(Figure 11B). From a biological standpoint, Spy1’s effects on mammospheres shows that 
Spy1 could be stimulating the stem cell self-renewal as well as proliferation. This is 
biologically relevant since stem cells are necessary in the mammary gland to rebuild the 
gland after involution. In a tumorigenic context, these mammary stem cells could 
transform and become cancerous where Spy1 could be stimulating these cancerous stem 
cells and promoting mammary tumorigenesis. 
In order to determine whether Spy1 affects the ability of a cell to form a MSs, a 
clonal assay was performed to calculate the efficiency of sphere formation. A small 
number (10 cells) of control and manipulated Spy1 cells were seeded individually in a 96 
well low attachment plate. Specifically, cells utilized in this assay were derived from 
dissociated passage 1 spheres. Cells had 7 days to form MSs at which time, wells were 
scored according to whether spheres had formed (see Design and Methodology for how 
sphering percentage was calculated). For the MCF7 overexpression, the pLXSN-control 
sphere-forming percentage was 17.7% whereas the MCF7 pLXSN-Flag-Spy1 sphere-
forming percentage was 8.1%, which was determined to be statistically significant at the 
p<0.001 level (Figure 11C). For the 231 cells, pEIZ-Flag-Spy1 cells yielded a 7.5% for 
their ability to form spheres whereas pEIZ cells yielded a 9.1% (Figure 11C). For the 
knockdown MCF7 cells, the pLKO-control sphering percentage was 4.5% and the 
pLKO-Spy1 sphering percentage was 5.7% (Figure 11C). Finally for the 231 knockdown 
Spy1 clonal assay, pLKO-control cells obtained a 3.8% in sphere formation abilities and 
the pLKO-Spy1 cells yielded a 4.9% (Figure 11C). 
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Diameter size was measured at the end of the clonal assay (Figure 11C). For the 
MCF7 spheres formed in the clonal assay, pLXSN-Flag Spy1 MSs were slightly smaller 
(128.8 um) than the pLXSN-control spheres (129.1 um) (Figure 11C). For 231 Spy1 
overexpression, pEIZ-Flag-Spy1 MSs formed larger spheres (104.8 um) than pEIZ-
control (93.3 um), which proved to be statistically significant relationship at the p<0.001 
level (Figure 11C). For Spy1 knockdown in the MCF7’s, pLKO-Spy1 MSs were larger 
(172.1 um) than the controls (117.1 um;  p<0.001) (Figure 11C). As well, 231 pLKO-
Spy1 formed spheres with small diameters (88.4 um) than pLKO-control (95.7 um) 
(p<0.001) (Figure 11C). In essence, the resultant MS diameters determined in the clonal 
assay were affected by Spy1 manipulation, just like MSs from the passaging experiments 
(Figure 11B & C).
To understand how Spy1 could affect other proteins and how these relationships 
could explain the effects of Spy1 on stemness, cells were collected and protein was 
extracted from each passage from the MCF7 cells containing either pLXSN-control and 
pLXSN-Flag-Spy1or MCF7 pLKO-control and pLKO-Spy1, as well as the  231 cells 
with the knockdown constructs pLKO-control and pLKO-Spy1 (Figures 11D, E, F). 
For MCF7 MSs containing the knockdown constructs, reduced Spy1 (Spy1-
pLKO) expression upregulated E-cadherin expression in both MS passages (Figure 11E). 
Consequently, -catenin levels were lower in the presence of pLKO-Spy1 expression, 
which appears to fit with literature that has shown that lower -catenin expression  
prevents stem cell self-renewal (Cajanek et al., 2009) (Figure 11E). As well, N-cadherin 
levels were upregulated across passages 1 and 2 of MCF7 pLKO-Spy1, which is 
surprising considering E-cadherin expression is also elevated (Figure 11E). With respect 
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to E-cadherin and N-cadherin, it is possible that Spy1 may be involved in maintaining the 
balance between stem cells (increased N-cadherin expression) and progenitors (increased 
E-cadherin expression) and this may explain why these two proteins are elevated in 
during MS culture (Klopp et al., 2010). Additionally, MCF7 Spy1 MS elicited higher -
catenin levels than controls, which seems to fit with literature that shows that -catenin 
stabilization can promote stem cell self-renewal (Perez-Ruiz et al., 2008).
In Figure 11D, protein levels were assessed for 231 knockdown Spy1 MSs. It 
must be mentioned that 231’s are E-cadherin negative and no expression of E-cadherin 
was ever observed via western blot analysis. However, it appears that in the early 
passages, 231 pLKO-Spy1 spheres exhibited higher N-cadherin levels than pLKO-control 
(Figure 11D). Interestingly, -catenin levels were also low in the presence of pLKO-Spy1 
(Figure 11D). In the MCF7 Spy1 overexpressing MSs, -catenin levels were elevated 
with elevated levels of Spy1 however, E-cadherin levels were only modestly elevated 
(Figure 11F) 
To assess potential alterations in gene expression associated with knockdown of 
Spy1 expression, 231 MSs containing pEIZ control or pEIZ-Flag-Spy1 were selected 
through passaging, RNA collected and gene expression analysed by Q-RT-PCR. 
Classical markers for mammary differentiation or stemness were utilized: i) 
differentiation marker, cytokeratin 18, ii) stemness markers, CD24, iii) another stemness 
marker, CD44, and iv) an embryonic stem cell marker, Oct4 (Figure 11G). pEIZ-Flag-
Spy1 MSs had slightly higher levels of CK18 than pEIZ-controls in the early MS 
passages and monolayer (Figure 11G). However in passage 4, 231 pEIZ-Flag-Spy1 MSs 
had slightly lower levels of CK18 than pEIZ-controls (Figure 11G). As previously 
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mentioned, researchers have discovered that mammary stem cells exhibit the CD24-
/CD44+ on their cell surface. Measuring these markers demonstrated that there was a 
variation in expression of stem markers across passages where, for instance, monolayer 
Spy1 overexpressing cells appeared to be more stem-like, in passages 1 and 3 the Spy1 
overexpressing MSs exhibited a less stem-like appearance but this was reversed in 
passages 2 and 4 where pEIZ-Flag-Spy1 MSs exhibited more of a stem-like appearance 
than control treated cells (Figure 11G). These same irregular variations were noted when 
measuring the pluripotency marker Oct4. Monolayer 231 pEIZ-Flag-Spy1 cells expressed 
higher amounts of Oct4 than their control counterparts, in the first MS passage cells 
overexpressing Spy1 showed lower levels of Oct4 and  subsequently in passages 2-4, 
Spy1 overexpressing MSs expressed higher levels of Oct4 than controls. 
In passaging experiments, Spy1 overexpression elicited larger MS, whereas Spy1 
knockdown showed a less clear trend where MCF7 knockdown Spy1 MS were larger and 
231 knockdown Spy1 MS were smaller. As well, 231 overexpressing Spy1 MS may have 
exhibited larger MS however, these MS did not elicit more stemness as the QRT PCR 
data displayed. The QRT PCR data showed that there may be inconsistencies using 
immortalized cell lines in MS culture. This may explain the irregular variation in the 
expression of stemness and differentiation markers across passages. The effects of Spy1 
on stem cell self-renewal is still in its infancy, so it would be necessary to perform more 
experiments to further clarify how Spy1 could affect mammary stem cells and how these 
effects could contribute to mammary tumorigenesis. 
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Figure 1. Spy1 Knockdown Increases Migration in MDA-MB-231 cel1s. Knockdown 
Spy1 (pLKO Spy1; grey bars) and Control cells (pLKO; black bars) in the presence and 
absence of LiCl were utilized for assessing:  A, Average cell numbers obtained over 2 
experiments using trypan blue analysis in triplicate counts. B, Migration pictures obtained 
from one set of experiments at 20x magnification. C, Optical density measured at 590 nm
over two experiments. D, Western blot of migration assay and densitometry graph to 
represent Spy1 (black bars) and -catenin (empty bars) expression levels of one 
experiment.
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Figure 2. Spy1 Knockdown Increases Migration in MCF7 cells. Knockdown Spy1 
(pLKO Spy1; grey bars) and Control cells (pLKO; black bars) in the presence and 
absence of LiCl were utilized for assessing:  A, Average cell numbers obtained over 2 
experiments using trypan blue analysis in triplicate counts. B, Migration pictures obtained 
from one set of experiments at 20x magnification. C, Optical density measured at 590 nm
over two experiments over 2 experiments. D, Western blot of migration assay and 
densitometry graph to represent Spy1 expression levels of one representative experiment.
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Figure 3. Spy1 Overexpression Decreases Migration in HC11 cells. Spy1 
Overexpression (pEIZ Flag Spy1; grey bars) and Control cells (pEIZ; black bars) in the 
absence and presence of LiCl were utilized for assessing: A, Average cell numbers
obtained over 3 experiments using trypan blue analysis (n=3). B, Migration pictures
obtained from one set of experiments at 20x magnification. C, Optical density measured 
at 590 nm (n=3, * p<0.05, *** p<0.001). D, Western blot and densitometry graph of -
catenin levels of one representative experiment.
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Figure 4. Spy1 Overexpression Decreases Migration in HEK 293 cells. Spy1 
Overexpression (pCS3 Myc Spy1; light bars) and Control cells (pCS3; dark bars) in the 
absence and presence of LiCl were utilized for assessing: A, Represented graph of 
average cell numbers obtained from 3 hour timepoint (from 3 experiments) to show trend 
of Spy1’s effects on proliferation through the use of trypan blue analysis. B, Migration 
pictures obtained from one set of experiments at 20x magnification. C, Optical density 
measured at 590 nm (n=3), * p<0.05, *** p<0.001). D, Western blot analysis and 
densitometry graph of -catenin (black bars) and E-cadherin (grey bars) levels of one 
experiment over different timepoints using one representative experiment.
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Figure 5. Spy1 Knockdown Decreases Adhesion in MDA-MB-231 cells. Knockdown 
Spy1 (pLKO Spy1; light bars) and Control cells (pLKO; dark bars) were utilized for 
assessing A, Average cell number obtained over 2 experiments using trypan blue 
analysis. B, Representative pictures from one adhesion timecourse experiment performed 
on plastic, collagen and fibronectin substrates at 20x magnification. C, Optical density 
measured at 590 nm over two experiments. (n=2). D, Western blot of adhesion assay and 
densitometry graph to represent Spy1 (black bars) and -catenin (grey bars) expression 
levels of one representative experiment.
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Figure 6. Spy1 Knockdown Decreases Adhesion in MCF7 cells. Knockdown Spy1 
(pLKO Spy1; light bars) and Control cells (pLKO; dark bars) were utilized for assessing
A, Average cell numbers obtained over 2 experiments using trypan blue analysis. B, 
Representative pictures from one adhesion timecourse experiment performed on plastic, 
collagen and fibronectin substrates at 20x magnification. C, Optical density measured at 
590 nm over two experiments. (n=2). D, Western blot of adhesion assay and densitometry
graph to represent Spy1 (black bars) and E-cadherin (grey bars) expression levels for one 
representative experiment.
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Figure 7. Spy1 Overexpression Increases Adhesion in HC11 cells. Spy1 Overexpression 
(pEIZ Flag Spy1; light bars) and Control cells (pEIZ; dark bars) were utilized for 
assessing: A, Average cell numbers from 3 replicates using trypan blue analysis. B,
Representative pictures from one adhesion timecourse experiment performed on plastic, 
collagen and fibronectin substrates at 20x magnification. C, Optical density measured at 
590 nm (n=3), * p<0.05, ** p<0.01, *** p<0.001). D, Western blot of adhesion assay of 
one representative experiment.
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Figure 8. Spy1 Overexpression Increases Adhesion in HEK 293 cells. Spy1 
Overexpression (pCS3 Myc Spy1; light bars) and Control cells (pCS3; dark bars) were 
utilized for assessing: A, Average cell numbers from 3 replicates using trypan blue 
analysis. B, Representative pictures from one adhesion timecourse experiment performed 
on plastic, collagen and fibronectin substrates at 20x magnification. C, Optical density 
measured at 590 nm (n=3), *** p<0.001). D, Western blot analysis of adhesion assay of 
one representative experiment.
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Figure 9. Spy1 Effects on Invasion. Spy1 Knockdown (pLKO Spy1; light bars) with 
Control cells (pLKO; dark bars) as well as Spy1 overexpression (pCS3 Myc Spy1; light 
bars) with Control cells (pCS3; dark bars) were utilized for assessing: A, Pictures from 
invasion assay of one representative replicate for knockdown and western analysis with 
quantification (lower panels). B, Pictures from invasion assay of one representative 
replicate for overexpression experiments (at 20x magnification) and western analysis
with quantification (lower panels). C, Optical density measured at 590 nm for both 
overexpression (n=3, ** p<0.01) and knockdown (n=3, *** p<0.001) studies.
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Figure 10. Spy1 Effects on -catenin’s Activity. HEK 293 cells were transfected with -
catenin luciferase reporter plasmid (TOPFLASH) and mutant -catenin luciferase 
reporter plasmid (FOPFLASH) in the absence LiCl (top graph) and with LiCl (bottom 
graph) to assess the effect of Spy1 on -catenin transcriptional activity. A, Graphs of 
luciferase assay of pCS3 (control) and pCS3 Myc Spy1, where the amount of 
bioluminescence was measured in counts per second (cps); Western blot analysis of -
catenin reporter assay with 293 Spy1 Overexpression without LiCl (n=1) and with LiCl 
(n=3). 
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Figure 11. Spy1 Effects on Stemness. A, Pictures of representative passages at 20x 
magnification. I, Two representative passages of MCF7 Control (pLXSN) 
mammospheres and MCF7 pLXSN Spy1 Overexpressing mammospheres and 
knockdown Spy1 mammospheres. II, Two representative passages of 231 Control (pEIZ) 
spheres and 231 Overexpressing mammospheres (pEIZ Flag Spy1). III, Two 
representative passages of MCF7 Control (pLKO) and  MCF7 Knockdown Spy1 (pLKO 
Spy1) mammospheres. IV, Two representative passages of 231 Control (pLKO) 
mammospheres and 231 Spy1 Knockdown (pLKO Spy1) mammospheres. B, Graph for 
average diameter size across four passages of mammospheres for knockdown Spy1 and 
overexpression (n=3). Graph for average number of spheres formed during four passages 
of mammospheres for knockdown and overexpression of Spy1 (n=3). C, Graphs for 
sphering abilities (in percent) for stable celllines of Spy1 knockdown and overexpression 
and average diameter size of spheres formed in clonal assay (* p<0.05, *** p<0.001). D 
Western blot analysis and densitometry of pooled 231 pLKO and pLKO Spy1 (shSpy1) 
mammospheres for Spy1, N-cadherin, -catenin protein expression across mammosphere 
passages (passages 1-4). E, Western blot analysis and densitometry of pooled protein 
lysats for MCF7 pLKO and pLKO Spy1 (shSpy1) mammospheres for Spy1, N-cadherin, 
-catenin protein expression across mammosphere passages (passages 1-4). F, Western 
blot analysis and densitometry of pooled MCF7 pLXSN and pLXSN Spy1 
(overexpressing Spy1) mammospheres for Spy1, N-cadherin, E-cadherin, and -catenin 
protein expression across mammosphere passages (passages 1-4). G, QRT PCR analysis 
of 231 overexpressing Spy1 mammospheres mRNA, where Spy1, Cytokeratin 18, CD24, 
CD44 and Oct4 were assessed across four mammosphere passages and monolayer and is 
representative of one experiment done in triplicate.
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IV. DISCUSSION
Although the mechanism of how Spy1 promotes mammary tumorigenesis is not 
completely understood, it is becoming well established that Spy1 contributes to 
mammary carcinogenesis through affecting essential cellular processes. Migration, 
adhesion, invasion, self-renewal and morphology are all processes that are affected in 
cancer, and understanding the effects of Spy1 on these processes is crucial in elucidating 
the multifaceted mechanisms of cancer.
Potential Mechanisms involving Spy1 in Mammary Tumorigenesis
Research has shown that Spy1 is involved in regulating the cell cycle through its 
interactions with Cdk2 (Porter et al., 2002) and that Spy1 overexpression can promote 
murine mammary tumorigenesis in vivo (Golipour et al., 2008). It has also been shown
that the expression of Spy1 is elevated in more aggressive tumors as well as in invasive, 
metastatic cell lines like MDA-MB-231 and MCF10CA1a (Al Sorkhy et al., 2010).  
Hence, it was of great interest to determine the importance of Spy1 expression in 
mammary tumorigenesis. Through studying the effects of Spy1 on cell migration and 
adhesion, it was determined that reducing levels of Spy1 could increase migration and 
decrease adhesion, two events that are essential for epithelial-mesenchymal transition 
(EMT) or metastasis to occur (Figure 1B, 2B, 5B, & 6B). As previously mentioned, EMT 
is a process that plays a crucial role in development, where cells are said to transition 
from a less motile, adherent, epithelial type cell into a motile, fibroblastic cell, which is 
necessary for the formation of the neural tube during mammalian development. In 
addition, loss of E-cadherin has been classified as biomarker for EMT and most data 
supports the hypothesis that a loss of cell-cell adhesion leads to EMT which in turn
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promotes metastasis (Huber et al., 2005). Blanco and colleagues discovered that in a rat
model of lung carcinogenesis that there was a consistent loss of adherens junctions and E-
cadherin, during tumor metastases (Blanco et al., 2004). EMT is also known to play a 
role in stimulating metastasis (Huber et al., 2005), where research has shown that EMT 
can cause the upregulation of mesenchymal markers, such as N-cadherin and vimentin, 
and downregulation of epithelial marker, mainly E-cadherin. Given this data, how could 
Spy1 fit into this metastasis/EMT model of tumorigenesis? The answer may lie with two 
proteins which Spy1 is intimately associated: c-Myc and p21. Spy1 has been shown to 
mimic c-Myc patterns during mammary gland development and to be upregulated by c-
Myc expression (Golipour et al., 2008); as well, Spy1 is able to inhibit p21 expression 
(Nebreda et al., 2000). Liu et al showed that when p21 was deleted that this caused an 
increase in c-Myc induced EMT and the presence of cancer stem cells as well, they 
showed that endogenous p21 could repress EMT in transgenic mice (Liu et al., 2009). 
Figure 12. Spy1 effects in contributing to EMT.
Putting all this information together, endogenous levels of Spy1 may be essential 
to help c-Myc promote EMT (Figure 12). Research shows that c-Myc overexpression can 
induce EMT through upregulating mesenchymal markers (Liu et al., 2009). However 
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results from our lab have shown that c-Myc overexpression can affect Spy1 expression 
(Golipour et al., 2008). In this scenario, it is possible that Spy1 endogenously initiates 
EMT through overriding p21, and as a result enhances c-Myc and transcriptional 
upregulation of the necessary markers for EMT to occur. It is important not to disregard 
that not all EMT models behave in a manner that is “typical” of EMT. In the literature, 
another protein has shown effects which appears to be comparable to Spy1 expression in 
tumorigenesis and metastasis. Caveolins are integral membrane proteins that are found in 
the majority of adherent, mammalian cells but have also been linked to tumors with a 
metastatic phenotype (Li et al., 2001). Lin and colleagues have demonstrated that an 
upregulation of caveolin-1 in pancreatic cancer cells led to a decrease in cellular 
migration, and downregulation of caveolin-1 caused an increase in cellular migration 
through activation of the p38 MAPK pathway; both scenarios promoted EMT by 
inhibiting RhoC (Lin et al., 2005).
However, keeping in mind the classic EMT model, it is possible that Spy1 
expression in tumorigenesis may not be so clear cut. It has been observed that Spy1 
knockdown can affect migration and adhesion to fit the EMT model (Figure 1B, 2B, 5B, 
6B). In addition, Spy1 overexpression has shown to increase invasion (Figure 9A) as well 
as increase -catenin transcriptional activity (Figure 10A), which are events that fit the 
EMT model. However, Spy1 overexpression effects on migration and adhesion exhibit 
opposing trends, where Spy1 overexpression causes a decrease in migration and an 
increase in cell-substrate adhesion. It is possible that Spy1 knockdown data is 
preliminarily showing that endogenous Spy1 levels may be involved in maintaining the 
balance between a regular tumor or metastasizing tumor (Figure 1B, 2B, 5B, 6B). 
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Although the role of Spy1 in mammary tumorigenesis is still unknown, potential 
mechanisms involving Spy1 could function in the following manner: Spy1 levels become 
ablated due to transformation, which may involve stimulation of c-Myc to induce EMT, 
and the downregulation of Spy1 leads to non-adherent and more motile cells. On the 
other hand, it is possible that Spy1 overexpression could be involved in helping tumor 
cells invade (Figure 9A) as well as colonize into a new microenvironment and promote 
tumor cell proliferation to form new metastases (Figure 7B & 8B). The ability of Spy1 
overexpressing cells to promote invasion fits the classical model of metastasis, which 
corroborates much of the literature that is known about metastasis and EMT (Jia et al., 
1999) (Leber et al., 2009).  However, further experimentation is crucial for dissecting the 
exact mechanism that Spy1 uses to promote mammary tumorigenesis. Even though Spy1 
is a novel protein whose role in tumorigenesis has yet to be defined, it is quite possible 
that Spy1 may be involved in promoting events to stimulate EMT or metastasis. 
Alternative Mechanisms involving Spy1 in Mammary Tumorigenesis
Another way of interpreting Spy1’s role in tumorigenesis could be through 
studying the effects of Spy1 on cell polarity. Cell polarity is an important event regulated 
by signals from the cellular environment to organize the cell into axes with known 
directionality.  In the mammary gland, cell polarity plays a major role in the formation of 
the mammary acini, where epithelial cells receive signals from neighboring cells and the 
ECM as to their role and position in the acini (Debnath et al., 2008). Spy1 overexpression 
causes disruptions in acini morphology in vitro (Golipour et al., 2008). As well, 3-
dimensional (3D) culturing of HC11 overexpressing Spy1 acini showed that these acini 
displayed disrupted morphology, specifically in shape and size, which could also point to 
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problems in cell polarization (data not shown). Disruptions in cell polarity have often 
been linked to disruptions in morphology (Hirata et al., 1998). In this study, the trend of a 
decrease in migration in the presence of Spy1 overexpression seems to fit well with cells 
that may have disrupted polarity (Figure 3B & 4B). Bershadsky and colleagues 
determined that when Golgi apparatus function was disrupted in mouse 3T3 cells that 
these cells lost their typical polarized morphology and lead to a decrease in cellular 
migration (Bershadsky et al., 1994). Disrupted cell polarity has also been identified as a 
characteristic of EMT (Huber et al., 2005).
Figure 13. The Effect of Spy1 on Cell Polarity and its Contributions to Tumorigenesis
Since Spy1 overexpression can disrupt morphology and migration, this may imply 
that Spy1 could be affecting cellular polarity by exhibiting effects on proteins from the 
non-canonical Wnt pathway, planar cell polarity (PCP), which has been a pathway 
involved in regulating developmental events such as cell polarization. Proteins from this 
pathway (Rho, Rac and cdc42) are all known regulators of the actin cytoskeleton. These 
proteins play important roles in regulating cellular events such as cell polarity and 
92
migration (Allen et al., 1997). Migrating cells undergo reorganization of the actin 
cytoskeleton as well as intracellular components (Allen et al., 1997). However one of 
these proteins, cdc42 has shown a governing role of cell polarity, where researchers 
observed that cdc42 overexpression could increase degradation of E-cadherin; an event 
that promoted EMT (Shen et al., 2008). The absence of E-cadherin has been correlated to 
disruptions in cell polarity (Shen et al., 2008). Although it is premature to speculate the 
role of Spy1in polarity, one can hypothesize an involvement in polarity based on the data 
demonstrating the effects of abrogated levels of Spy1 in mammary morphology (data not 
shown). Although one could speculate about how Spy1 could affect mammary 
tumorigenesis, it is possible that Spy1 may be involved regulating cell polarity through 
affecting the PCP pathway, where in vitro work showed that Spy1 could disrupt acini 
morphology (Figure 13) (Golipour et al., 2008). Since Spy1 could be affecting cellular 
polarity, it may also be possible that Spy1 could have effects on cdc42, a PCP protein that 
has been shown to regulate cell polarity (Shen et al., 2008). Effects of Spy1 in cellular 
polarity could also cause defects in cell adhesion, which is a phenotype that Spy1 
knockdown cells exhibited (Figure 5B & 6B). Conversely, effects may be more global in 
that Spy1 could affect various PCP mediators (Rac and Rho) and disrupt their expression 
and how they regulate the actin cytoskeleton and hence migration and adhesion, which 
could explain how Spy1 could be disrupting cellular migration, in both knockdown and 
overexpressing experiments. 
Potential Mechanisms involving Spy1 in Regulating Self-Renewal
Stem cell research has become more prevalent in the recent years where 
researchers are beginning to establish links between stem cell regulation and 
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tumorigenesis. In the literature, many mechanisms that govern stem cells and their niche 
have been observed to be greatly affected during tumorigenesis. The cancer stem cell 
hypothesis states that a small pool of cells, contained within the tumor, acquire self-
renewing abilities which can promote tumorigenesis (Tan et al., 2006). The expression of 
Spy1 has shown to be elevated during puberty, early pregnancy and involution (Golipour 
et al., 2008). As previously mentioned, involution is a period where mammary stem cells 
are recruited to begin to rebuild the mammary gland, so it was especially interesting to 
see if Spy1’s expression during involution could be correlated to stem cell self-renewal. 
Mammospheres, which are derived from stem cells, were utilized to assess Spy1’s effects 
on stem cell self-renewal with respect to effects on mammosphere passaging, numbers 
and mammosphere formation in the presence of Spy1 manipulation.
The present evidence supports that Spy1 may affect stem cells self-renewal. 
Results showed that Spy1 overexpression elicited larger spheres (Figure 11A I) and Spy1 
knockdown caused smaller spheres to form in basal breast cancer cells (Figure 11A IV). 
So questions to ask here are: How does Spy1 affect stem cell self-renewal? How could 
Spy1’s effects on stem cells contribute to tumorigenesis? 
How does Spy1 affect Stem Cell Self-Renewal?
Stem cell literature remains divided in terms of identifying a true stem cell 
phenotype, however research has shown that stem cells can produce larger and more 
mammospheres (Dey et al., 2009) (Grimshaw et al., 2008). The best way to establish a 
mammary stem cell phenotype is through utilizing Fluorescence Activated Cell Sorting 
(FACS), where putative stem cell surface markers CD44 and CD24 were identified 
(Dontu et al., 2003). In the QRT PCR data, these data seem to fit with certain passages of 
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231 pEIZ Spy1 mammospheres, where in certain passages Spy1 overexpressing 
mammospheres exhibited a more stem like appearance than their controls. However 
looking at stemness markers (CD24, CD44 and Oct4), there were no clear trends that 
were visualized that exhibited an increasing or decreasing trend of stemness (Figure 
11G). It appeared that both stemness and differentiation markers varied in an irregular 
pattern, which made it very hard to discern a clear relationship between Spy1 and 
stemness and to fully prove effects of Spy1 in stem cell self-renewal. Interestingly in 
monolayer, Spy1 overexpressing cells exhibited a more stem like appearance (low CD24, 
high CD44 and high Oct4 expression) in comparison to all the mammosphere passages 
(Figure 11G).
Self-renewing abilities were also assessed utilizing the clonal assay which gave a 
measure of how efficiently certain immortalized cell lines could form mammospheres. 
Spy1’s results from the clonal assay showed some perplexing results where 
overexpressing Spy1 cells had reduced abilities to form spheres whereas knockdown 
Spy1 cells had enhanced abilities to form spheres (Figure 11C). In order to corroborate 
the claim that Spy1 is a positive regulator for stemness, it is necessary to refer back to 
Spy1’s ability to affect adhesion. As previously studies shown, Spy1 overexpression 
could enhance adhesion, which may help to explain Spy1 overexpressing cells’ lower 
sphering percentages. In this scenario, Spy1 could be increasing adhesion between stem 
cells, thereby inhibiting stem cells from forming more spheres. In the knockdown Spy1 
assay, stem cells do not have to overcome Spy1’s adhesion effects and so are able to form 
more spheres. In addition, the mammosphere passaging experiments gave stem cells 
ample room in a six well plate to form spheres whereas in a 96 well plate, stem cells were 
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faced with an obstacle of adhesion effects by Spy1.  In essence, these results marginally 
relay Spy1’s ability to affect stem cell self-renewal. Coupled with the gene expression 
data, it is difficult to characterize Spy1 as a direct stem cell effector. However, further 
experimentation would be necessary to establish whether Spy1 can actually affect stem 
cell self-renewal.
Spy1 is a known cell cycle regulator that has been shown to bind and activate 
cdk2 as well has been shown to cause p27 degradation (Porter et al., 2002) (Porter et al., 
2003). Interestingly, p27 and cdk2 both have shown association with affecting stem cells. 
Jablonska and colleagues demonstrated that cdk2 was essential for maintaining neuronal 
stem cell self-renewal (Jablonska et al., 2007). As well, Cheng and colleagues 
demonstrated that p27 does not affect stem cell number or self-renewal but p27 
overexpression can enhance the progenitor cell pool (Cheng et al., 2000). In essence, 
Spy1 could promote self-renewal through its interactions with cdk2 and in this complex, 
lower levels of p27, which could act as a mechanism to maintain homeostasis with stem 
and progenitor cell pools within their niche. Another Spy1 related protein that functions 
in this manner is c-Myc where it was shown that c-Myc was involved in maintaining 
stem cell differentiation through creating a balance between stem and progenitor cells 
(Baena et al., 2007).  Looking at all the stemness data, it is possible that Spy1 could be 
affecting stemness in a manner similar to c-Myc. Through its interaction with Cdk2 and 
p27, Spy1 could be maintaining homeostasis between stem and differentiated cells. So if 
the stemness/differentiation balance is shifted in either direction, Spy1 overexpression 
could compensate for both pools of cell types and establish homeostasis once again. 
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Additionally, catenin is a major mediator in the Wnt signaling pathway and its 
elevated expression has been correlated with many types of tumors and has been linked to 
influencing stem cell self-renewal (Chen et al., 2007). So throughout all the experiments 
performed in this thesis, it appeared that a relationship between Spy1 and catenin was 
developing, where catenin were low with Spy1 knockdown cells and were elevated in 
Spy1’s overexpressing cells (Figure 1D, 2D, 3D, 4D). As well, Spy1 overexpression was 
able to enhance catenin’s transcriptional activity (Figure 10A). It is not surprising that 
this relationship became more evident throughout these studies because a yeast 2 hybrid 
assay performed in our lab showed that Spy1 could interact with Wnt mediators, Axin 
and LRP6. Zeng and colleagues postulated another manner of interpreting the Wnt 
pathway where Axin, active GSK3 and LRP6 form a complex to promote catenin
stabilization (Zeng et al., 2008). So it is possible that Spy1 is interacting with Axin/GSK3 
and LRP6 to keep catenin levels high to help stem cell undergo self-renewal in their 
niche (Figure 14). Or Spy1 could be functioning with catenin to maintain homeostasis 
between stem and progenitor cells within the stem cells niche. In this context, catenin
would be involved in maintaining the stem cell numbers and Spy1 could be maintaining 
the progenitor cells. Or Spy1 with catenin could be working synergistically to enhance 
the stem and progenitor cell pools. Additionally, Spy1’s effects in migration and adhesion 
may also play a role in maintaining the stem cell niche through promoting adherence and 
preventing migration from their niche. Like with the previous studies, supplementary 
work would need to be done in order to prove how Spy1 and catenin contribute to 
affecting stem cells and how this relationship contributes to mammary tumorigenesis.
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Figure 14. Effects of Spy1 in Stem Cell Self-Renewal 
How do effects of Spy1 on Stem Cells Contribute to Tumorigenesis? 
Spy1’s overexpression has shown its effects in stemness through its ability to 
enhance mammosphere diameter size and number. However from a tumorigenic 
standpoint, one can ask the question: How do Spy1 effects on stemness contribute to 
tumorigenesis? In order to answer this question, it is imperative to revisit the stem cell 
hypothesis, which essentially states that tumors contain a small population of tumorigenic 
cells, with self-renewable abilities, that perpetuate tumor formation. Could Spy1 affect 
these cancer stem cells?
It is quite possible that Spy1 could affect how cancer stem cells adhere to their 
niche, promote their self-renewal and proliferation. Results showed that Spy1 
overexpression could affect mammosphere size and number, which could suggest that 
Spy1 is essential to self-renewal for both normal and cancerous stem cells. As Figure 4 
shows, Spy1 could be enhancing stem cell self-renewal in two ways: i) through its 
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interactions with cdk2 and effects on p27 and ii) through its interactions with Axin, LRP6 
to help stabilize -catenin (Figure 14). It is possible that Spy1 could help cancer stem 
cells through providing a suitable microenvironment where cancer stem cells can: adhere 
better to their niche, enhance their proliferation, which in turn could help propel their 
self-renewal abilities. If Spy1 could have potentially this much control over cancer stem 
cells, then it is possible for Spy1 to become an essential biomarker for breast cancer, 
where Figure 5 shows how targeting Spy1 could be targeting a tumor at it source. 
Additionally, Spy1’s effects with stemness as well as with its links to EMT could provide 
a potential mechanism of forming more aggressive types of tumors that have a high 
likelihood to metastasize, which would make Spy1 a very favorable marker for breast 
cancer. 
Figure 15.  Mechanism involving potential role of Spy1 in Mammary Tumorigenesis.
Breast cancer is an extremely intricate process, however how Spy1 fits into the 
cancer mechanism remains to be seen. It will take time to fully clarify Spy1’s role in 
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mammary tumorigenesis, however results so far have made small strides in understanding 
this difficult disease. 
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V. FUTURE DIRECTIONS
Understanding the role of Spy1 in mammary tumorigenesis is far from being 
complete, there is still much more work that needs to be done to prove the potential of 
this novel cell cycle regulator as biological target for breast cancer and metastasis. 
Although Spy1 overexpression had lead to decreases in migration, it would be vital to 
clarify how Spy1 is affecting migration through determining links between Spy1 and 
pathways known to regulate cellular migration. As previously mentioned, it would be 
interesting to establish links between Spy1 and the Rho pathway, specifically looking at 
cdc42. Cdc42 has been shown to regulate polarity in migrating cells, so it would be of 
great interest to knockdown cdc42 and re-perform the migration assays or perform wound 
healing assays and see how migration and polarity are affected in Spy1’s presence and 
absence. 
To better clarify the role of Spy1 in adhesion, it would be essential to determine 
the effects of Spy1 on adhesion to various substrates in the presence of knocked down 
expression of E-cadherin, N-cadherin and -catenin. Additionally, it would be important 
to perform experiments to determine the interactions between Spy1 and p21 and how this 
could potentially impact c-Myc induced EMT. For instance, one could utilize 
overexpressing myc primary tumor cells and knockdown Spy1 and determine protein and 
mRNA levels of epithelial and mesenchymal markers to determine the relevance of Spy1 
and p21 in c-Myc induced EMT. It would also be essential to perform a microarray 
analysis, derived from a Spy1 overexpressing primary tumor, and study the expression 
changes of various mesenchymal and epithelial markers. It would of great interest to take 
Spy1 overexpressing primary cells and use flow cytometry to determine the expression of 
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mesenchymal and epithelial with respect to Spy1. It is essential to implicate Spy1 with 
EMT markers that are well established in literature to begin to fit Spy1 signaling into 
these known pathways thereby strengthening the claim of Spy1’s role in tumorigenesis 
and metastasis. 
For Spy1 affecting stem cell self-renewal, it is imperative to perform a 
fluorescence activated cell sorting (FACS) of Spy1 overexpression and knockdown in 
primary mammary cells on various stem and differentiation markers and then compare 
these results against a microarray to establish a expression signature for Spy1 (Andrechek 
et al., 2008). After performing FACS, Spy1 manipulated cells would be sorted, and then 
mammospheres could be grown in culture to be injected into mice to determine Spy1 
effects on tumor formation.
Preliminary work with the immortalized but non-tumorigenic cell lines MCF10a 
and HC11 3D acini has further corroborated the ability of Spy1 to disrupt normal 
mammary morphology. In the MCF10a overexpressing Spy1 acini, it was observed that 
these acini formed disrupted, multi-acinar structures, where HC11 overexpressing Spy1 
acini were larger and also displayed a disordered morphology. Since these experiments 
were just beginning to come together at the conclusion of this thesis it is essential to grow 
3D acini with Spy1 overexpression and knockdown to study the effects. In addition to 
this, it would be essential to create stable Spy1 overexpression and knockdown cell lines 
using the cancer series cell lines to further clarify Spy1’s role in tumorigenesis in a 
relevant human breast model. Specifically, it would be important to grow these cell lines 
in 3D to determine consequences of Spy1 on acini development as well as count and 
measure mammary acini to get a full developmental summary of the effects of Spy1 on 
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mammary acini under normal and abnormal conditions. In addition, it would be essential 
to perform localization studies to verify Spy1’s expression in acini development 
specifically looking at effects on proliferation, apoptosis and polarity. Furthermore, 
assessing Spy1 protein levels in this model system along with markers to verify 
localization and morphology is a vital next step for this work. 
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